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Nucleic acid aptamers are short oligonucleotides that can bind specifically to a 
wide range of targets, making them an analogue to the more widely known amino acid- 
based antibodies. Aptamers are selected from a random oligonucleotide library by a 
method called systematic evolution of ligands via exponential enrichment (SELEX), 
originally described in 1990. The purpose of this dissertation is to highlight new uses for 
aptamer biosensors, as well as new methods for their selection. 
We envisioned that a high throughput enantiopurity assay using DNA aptamers 
(Chapter 2) would be especially powerful in the directed evolution of stereoselective 
enzymes. As a proof of concept, we used tyrosinamide to demonstrate our enantiopurity 
analysis method. However, as a compelling target for enzyme evolution, we were drawn 
to the molecule 2-chloromandelic acid (2-CMA), since it is a key intermediate in the 
synthesis of Clopidogrel (Plavix) and can be generated asymmetrically using engineered 
P450 enzymes. In order to select an aptamer for 2-CMA, we used several known bead-
based SELEX methods (Chapter 3). While we were able to select for several aptamers 
using these methods, ultimately we found that conversion of these aptamers into 
structure switching biosensors was difficult. This inspired us to explore SELEX methods 
that could directly select for the required biosensor architecture. We initially explored 
bead-based structure-switching SELEX methodologies. These methods directly link the 
structure switching architecture to ligand binding. However, we found that we 
predominately obtained false positives using these methods. 
Thus, we instead chose to explore capillary electrophoresis (CE) as our 
iv 
 separation method due to its high partitioning potential. Using a drag tag and 
complementary strand, we hypothesize that we will be able to directly select for structure 
switching aptamers using this method. This method offers the potential to remove the 
current bottleneck of our enantiopurity analysis method by allowing for rapid 
development of new structure-switching biosensors for targets of interest. 
Chapter 4 describes the development of a scalable and cost-effective synthesis 
for the protected N-[2-(Fmoc)aminoethyl]glycine benzyl ester backbone for peptide 
nucleic acids (PNA). PNA has emerged as a promising alternative to the native nucleic 
acids DNA and RNA for a wide variety of applications, including antisense therapy and 
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CHAPTER 1
APTAMERS AS AFFINITY REAGENTS AND BIOSENSORS
Introduction
Nucleic acids encode the genetic information for all living organisms, and are un-
rivaled in their capacity to store and transmit this information. DNA in particular is highly 
stable, and mere picograms of material can store an entire genome. Additionally, nucleic 
acids have powerful self-recognition properties arising from Watson-Crick base pairing 
(Figure 1.1). By exploiting the unique recognition ability of DNA, researchers have de-
veloped DNA nanostructures that are capable of self-assembly into lattice structures.1-2 
Moreover, DNA-templated reactions have been used for a myriad of tasks, including 
small-molecule and protein detection. Further, the self-recognition ability of DNA has 
been shown to be an effective tool for the detection of abasic sites and other mutations 
within DNA. However, all of these systems have traditionally depended only upon the 
affinity of two complementary DNA strands for one another. 
The excellent molecular recognition capabilities of nucleic acids can also be used 
for detecting non-nucleic acid targets, enabling the design of analytical biosensors. 
These biosensors are generally composed of an aptamer recognition element and a 
transducer, which converts physical or chemical changes into a measurable signal.  
Aptamers are short nucleic acid sequences selected to have affinity for specific 
targets through an in vitro evolution process referred to as Systematic Evolution of Lig-









Figure 1.2. Target-bound SELEX cycle. Target (green star) is bound to a solid support 
and incubated with a random library containing primer binding sites. Target-bound library 
is collected and amplified through PCR using a PEG-T20-modified reverse primer. Dena-
turing poly acrylamide gel electrophoresis is used for strand separation. The enriched 
library is now ready for another round or sequencing. 
2
leic acids can serve as affinity reagents for non-nucleic acid targets, over 1000 papers 
have been published on their many uses in the detection of ligands, ranging from whole 
cells to small molecules. Aptamers are emerging as the affinity reagent of choice in 
many fields due to their ease of use, cost effectiveness, and reproducibility of their 
chemical synthesis and in vitro selection processes. Further, the versatility of these mol-
ecules has led to their rapid incorporation in new technologies.  The state of the field re-
garding analytical applications of nucleic acid aptamers has been extensively reviewed.6  
Nucleic Acid Aptamers
Aptamer-based biosensors can be classified by their mode of detection, which 
encompasses a variety of platforms, including fluorescence, colorimetric, electrochemi-
cal and mass-sensitive readouts.6-7 The majority of these detection methods rely upon a 
conformational change of the aptamer upon target binding to induce signal transduction. 
This dissertation will predominately focus on fluorescence-based detection and the chal-
lenges involved in transforming an affinity reagent into a functioning biosensor. 
Fluorescence-based aptamer assays typically involve fluorophore and quencher 
moieties that can undergo a change in their spatial orientation upon binding of the target 
molecule. Fluorescence detection is widely employed due to its rapid signal output, wide 
fluorophore variety, sensitivity, and ease of fluorophore attachment. Traditional molecu-
lar beacons utilize nucleic acid probes end-labeled with a fluorophore and quencher, 
which form hairpin structures resulting in quenching of the florescence. Upon hybridiza-
tion with a complementary sequence, the beacon undergoes a conformation change that 
increases the distance between the fluorophore and quencher, resulting in an increase 
in fluorescence. Inspired by this design, Ellington and coworkers designed a thrombin-
binding molecular aptamer beacon, for the detection of thrombin  (Figure 1.3).8 In the 
presence of thrombin, the aptamer undergoes a conformational change, resulting in an  
3
Figure 1.3. Molecular aptamer beacon. Introduction of target leads to a conformational 
change, resulting in an increase in fluorescence intensity.
increase in fluorescence signal. This system was able to detect thrombin at concentra-
tions of less than 10 nM, showing that the process of converting the aptamer into a mo-
lecular beacon did not significantly decrease the binding affinity. However, this approach 
is far from generalizable, as many aptamers adopt random conformations in solution and 
the preorganization of the hairpin can therefore have detrimental effects on target bind-
ing. An alternate approach presented by Landry and coworkers utilized probes known as 
reverse aptamer beacons (Figure 1.4).9 In this system, an aptamer sensitive to cocaine 
was end-labeled with a fluorophore and quencher. In the absence of target, the aptamer 
was shown to favor a random orientation in solution, and thus exhibited high fluores-
cence. Incubation with cocaine promoted aptamer folding, resulting in fluorescence 
quenching and the detection of cocaine down to 10 μM in blood serum. An extension of 
this system can be seen in recently developed split-aptamer biosensors. 
Split-aptamers consist of two nucleic acid strands that only associate in the pres-
ence of a specific target. The two fragments can be labeled with a fluorophore and 
quencher, and in the absence of target, they will remain free in solution. Upon incubation 
with the desired target, the two fragments will assemble, resulting in fluorescence 
quenching. Szostak and coworkers demonstrated the first example of a split-aptamer for 








Figure 1.4. Reverse molecular aptamer beacon. Introduction of target leads to a con-
formational change resulting in formation of a structure stem loop producing a decrease 













Figure 1.5. Design and function of a split-aptamer. The two split-aptamer fragments as-




was modified and split within a loop region to create this unique architecture. Limitations 
for split-aptamer systems stem from the delicate thermodynamic balance required to 
eliminate nonspecific assembly of the fragments. This limitation results in weakly forming 
complexes that generally have poor affinity for the target molecule, decreasing their sen-
sitivity and thus their utility as analytical sensors. The Heemstra lab has pioneered a po-
tential solution to this challenge by incorporating a covalent proximity ligation event upon 
the target-induced association of the split-aptamer fragments (Figure 1.6).11 This system 
greatly increases the utility of split-aptamer technology through signal amplification, as 
each target molecule can induce the ligation of several aptamer-fragment pairs. Unfortu-
nately, rational design of split-aptamers is a difficult task due to the complex binding and 
structural organization requirements needed to achieve selective assembly in the pres-
ence of the target.  
In 2001, Li and coworkers recognized that none of the available approaches 
were generalizable to create aptamer biosensors for a wide variety of targets. Conse-
quently they introduced the structure-switching aptamer as a potential solution to cir-
cumvent this issue. Structure-switching aptamers generally consist of a short displace-
ment strand that is complementary to a region of an aptamer. The aptamer can be la-
beled with a fluorophore, while the displacement strand is functionalized with a quench-
er. In the absence of the target, the two strands hybridize, leading to low fluorescence. 
Upon introduction of the target molecule, the aptamer undergoes a conformational 
change that displaces the quencher strand, leading to dose-dependent fluorescence re-
covery (Figure 1.7). Li and coworkers showed the first proof of concept for structure-
switching biosensors using the known ATP and thrombin aptamers.12 This approach was 
seen as a highly generalizable method for converting any known aptamer into a biosen-










Figure 1.6. Split-aptamer covalent proximity ligation using strain promoted azide-alkyne 

















that undergo large conformational changes upon target binding. Unfortunately, while 
larger targets, like proteins, typically produce significant conformational changes upon 
binding to aptamers, small molecules generally lead to relatively small changes in the 
structure of the aptamer upon binding. This is likely due to the limited number of recogni-
tion elements and lack of physical bulk of small-molecule targets, which obviates the 
need for complex folding upon aptamer binding. As a result, only a handful of small-
molecule-binding aptamers have been successfully converted to structure-switching bio-
sensors in the 13-year time period since this system was first introduced.  
 
Small-molecule-binding aptamers
The first law of directed evolution states that “You get what you screen for.”13  
When performing traditional aptamer selections, the primary goals are high specificity 
and selectivity. These goals are often met for targets of all sizes, producing very robust 
affinity reagents. While it has become trivial to select aptamers that can perform as af-
finity reagents, converting these aptamers to biosensors remains a critical challenge. As 
previously described, the requirement of a significant conformational change is evident 
in all of the previously described sensor formats. Conformational changes are common 
for protein-binding aptamers, due to the target being larger than the aptamer, but it is 
only by chance that a small-molecule-binding aptamer undergoes a significant change in 
conformation upon target binding. The paucity of small-molecule-binding structure-
switching aptamer sensors in the literature is testament to the challenges inherent in 
generating this architecture using traditional selection approaches. 
According to the first law of directed evolution, the SELEX process must require 
a significant conformational change upon target binding to ensure that the resulting ap-
tamers will display this property. Morse and coworkers proposed a novel selection meth-
od known as “structure-switching SELEX” that fulfills this requirement.14 This method us-
8
es a short capture strand attached to a magnetic bead that is complementary to the 5’ 
primer binding site of a random RNA library (Figure 1.8). This method only enriches se-
quences that are displaced from the capture strand upon target binding, thereby directly 
selecting for the structure-switching architecture. The requirement of displacement upon 
target binding was shown to simultaneously select for specificity, selectivity, and induc-
tion of an appropriate conformational change. Using this method, RNA aptamers select-
ed for tobramycin were easily converted to structure-switching biosensors. Capture-
SELEX is an alternative approach using DNA that was later demonstrated by Strehlitz 
and coworkers.15 Instead of forcing the 5’ primer binding site to be involved in aptamer 
binding like the Morse design, they placed the docking region within the random region 
of the library (Figure 1.9). This design was anticipated to allow for greater diversity in the 
library by distancing the aptamer binding events from the fixed primer binding sites of the 
library. This method was successfully used to select several aptamers for kanamycin A. 
Unfortunately, the authors did not test the ability of the aptamers to function as structure-
switching biosensors, instead determining the binding affinities through a competitive 
elution approach. This competitive elution assay was performed similarly to the selec-
tions, by annealing each aptamer to magnetic beads coated in capture strand, followed 
by incubation with kanamycin A and quantification of the disassociation events via fluo-
rescence. While our lab was able to successfully repeat the competitive elution assay 
from this paper, we were unable to successfully convert any of the aforementioned ap-
tamers for kanamycin A to structure-switching biosensors. However, these selection 
methods provide a promising stepping stone for our efforts to reliably generate aptamers 
having the unique privileged structure-switching architecture.  
9
Figure 1.8. Library design for structure-switching SELEX.
Figure 1.9. Library design for Capture-SELEX. 
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Objectives of This Dissertation
Since the discovery of Watson-Crick base pairing and the powerful recognition 
capabilities of nucleic acids, scientists have strived to realize the full potential of these 
fascinating biological molecules. Aptamers, which resulted from this scientific movement, 
are poised to overtake antibodies as the preferred choice for many biosensing applica-
tions. Unlike antibodies, aptamers can be chemically synthesized giving little to no 
batch-to-batch variation. Additionally, aptamers are selected through an in vitro process, 
allowing for a wider range of targets to be used.  Although great strides have been made 
in the field of aptamer biosensor development for large targets, there is still a void in the 
literature for small-molecule-binding analogs. While new technologies for aptamer bio-
sensors progress, their utility hinges on finding a generalizable, rapid, and robust meth-
od for their selection. This dissertation primarily focuses on advancing aptamer technol-
ogies and furthering the aptamer field as a whole by addressing this key limitation. 
Chapter 2
Chapter 2 describes a novel screening method that explores a new application 
for structure-switching aptamer biosensors. This was accomplished through the use of 
orthogonal L- and D-DNA structure-switching biosensors to simultaneously measure 
both concentration and enantiopurity of mixtures of tyrosinamide enantiomers. Engi-
neered enzymes can perform a myriad of chemical transformations with high enantiose-
lectivity, but they must be discovered through extensive screening of enormous mutant 
libraries. The Heemstra lab recognized this as the key bottleneck to the progression of 
the field of biocatalysis, and therefore worked to design a rapid, simple method to in-
crease the rate at which libraries may be screened.  
11
Chapter 3
We hypothesized that if a SELEX method could be validated using an extremely 
small molecule with a limited number of functional groups, then this method would likely 
be capable of producing structure-switching aptamers for nearly any target. We investi-
gated this in Chapter 3 by selecting aptamers for the small molecule (S)-2-
chloromandelic acid (2-CMA) through modifications of known structure-switching SELEX 
methods and introduction of novel separation techniques utilizing capillary electrophore-
sis (CE). Our interest in 2-CMA was two-fold: first, it is an extremely difficult target for 
structure-switching aptamer selections and second, 2-CMA can be asymmetrically syn-
thesized through the use of an enzymatic reaction that has yet to be made commercially 
viable due to insufficient stereoselectivity. The growing interest in new methods to effi-
ciently screen enzyme-catalyzed reactions for enantiopurity makes 2-CMA a compelling 
target for our studies. 
Chapter 4
The Heemstra lab is also interested in the development of technologies utilizing 
non-native nucleic acid backbones. Peptide nucleic acids (PNA) are of particular interest 
to the biological community due to their high nuclease stability and affinity for DNA and 
RNA. In working with PNA, we recognized a deficiency in the literature for a simple, 
scalable synthetic route to generate the protected backbone. As such, Chapter 4 
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CHAPTER 2
ENANTIOSELECTIVE APTAMER BIOSENSORS FOR THE HIGH-THROUGHPUT 
SCREENING OF ENZYME-MEDIATED REACTIONS1
Introduction
Biological systems are exquisitely adept at producing small organic molecules 
with high stereoselectivity, as different stereoisomers of a molecule can illicit markedly 
different biological effects.1  Achieving high stereoselectivity plays an equally important 
role in many applications of synthetic organic chemistry, as the target molecules are of-
ten intended to interact with biological systems, for example in the case of small-
molecule therapeutics. Asymmetric catalysis has proven to be a revolutionary technology 
for the stereoselective synthesis of small molecules,2 and high-throughput screening 
(HTS) can be used to accelerate the optimization of reaction conditions for a particular 
synthetic transformation.3-10 In HTS, reaction conditions including catalyst, solvent, and 
temperature can be sampled combinatorially, and the implementation of robotics enables 
a large number of reactions to be run in parallel.  However, the analysis of these reaction 
mixtures for yield and stereoselectivity remains a severe bottleneck that hinders the dis-
covery of improved catalysts and reaction conditions.  
Chemical reactions that produce a mixture of enantiomers pose an especially 
_______________________ 
1Adapted under the terms of the Standard ACS AuthorChoice/Editors’ Choice usage agreement 
from Feagin, T. A.; Olsen, D. P. V.; Headman, Z. C.; Heemstra, J. M. High-Throughput Enanti-
opurity Analysis Using Enantiomeric DNA-Based Sensors. J. Am. Chem. Soc. 2015 137, 4198 
challenging analysis problem, as enantiomers have nearly identical physical properties.  
The current gold standard for measuring yield and enantiopurity is chiral high perfor-
mance liquid chromatography (HPLC). However, even under optimized conditions, 
HPLC is only capable of analyzing approximately 800 samples per day.11-12 A large num-
ber of alternative analysis platforms have been explored, including gas chromatography 
(GC),13 capillary electrophoresis (CE),14-16 circular dichroism (CD),17-19 infrared thermog-
raphy,20 mass spectrometry (MS),21-22 and enzymatic methods.23 Notably, new MS meth-
ods have been developed that enable the analysis of up to 10,000 samples per day,22 
but even this level of throughput is not sufficient to scan the vast libraries of reaction mix-
tures that can plausibly be generated in catalyst development and reaction optimization.3 
Moreover, many of these methods can accurately analyze enantiopurity, but provide little 
information regarding reaction yield.   
In contrast to the analysis platforms listed above, fluorescence-based methods 
have potential to enable exceptionally high throughput, as a 1,536-well plate can be ana-
lyzed in less than  1  minute.24    A number of laboratories have reported elegant ap-
proaches for fluorescence-based enantiopurity analysis of small molecules containing 
specific functional groups, such as α-hydroxycarboxylates, diols, and carboxylic acids.25-
27 We envisioned the development of a complementary approach in which a single small-
molecule target (or small handful of structurally similar targets) can be rapidly analyzed 
for enantiopurity, but without the requirement for specific functional groups.  While this 
approach may find limitations for use in the development of new reaction methodologies, 
where large substrate scope is beneficial, it is ideal for use in reaction development for 
high-value compounds, such as pharmaceuticals and their synthetic intermediates.  In 
the latter case, a tremendous amount of effort is focused on the development of opti-
mized reaction conditions for a single molecule or small subset of molecules, and thus 
achieving high throughput takes priority over substrate scope. 
15
Our approach to high-throughput enantiopurity analysis relies on molecular 
recognition of the target molecule using a DNA aptamer.  Aptamers are short nucleic ac-
id sequences that can be generated in vitro to bind a wide range of targets including 
small molecules, proteins, and cell types.28-30 Importantly, because aptamers are gener-
ated in vitro, negative selections can be utilized to increase substrate selectivity, and ap-
tamers have been reported which bind to one enantiomer of a small molecule with 
greater than 10,000:1 selectivity over the opposite enantiomer.31 In utilizing aptamers for 
high-throughput enantiopurity measurement, the first key element to our approach is the 
concept of reciprocal chiral substrate selectivity.  DNA is a chiral molecule, and thus if a 
native D-DNA aptamer binds selectively to one enantiomer of a small molecule, then by 
definition, the same aptamer sequence synthesized from non-native L-DNA (referred to 
as the Spiegelmer from the German word “Spiegel” meaning “mirror”)32-35 will bind to the 
opposite enantiomer of the small molecule with identical selectivity and affinity (Figure 
2.1a-b). 
The second key element to our approach is the ability of nucleic acid aptamers to 
transduce the presence of a specific molecule into a dose-dependent fluorescence out-
put.  This can be achieved in a number of formats,36 and for our enantiopurity analysis 
approach, we chose to utilize what is arguably the most straightforward of these formats, 
the structure-switching biosensor.37-38 In the structure-switching biosensor format, a short 
complementary strand is hybridized to the aptamer via Watson-Crick base pairing.  
However, in the presence of the target molecule, the aptamer preferentially binds to the 
target, displacing the complementary strand.  If the aptamer and complementary strand 
are labeled with a fluorophore and quencher respectively, then the target ligand will pro-
duce a dose-dependent increase in fluorescence signal. 
Applying the concept of reciprocal chiral substrate selectivity to structure-
switching biosensors, we designed a system in which the D- and L-DNA biosensors are  
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Figure 2.1. DNA enantiomers (a) Chemical structures of native D-DNA and enantiomeric 
L-DNA (Spiegelmer). (b) In accordance with the principle of reciprocal chiral substrate
selectivity, D- and L-DNA aptamers will bind to opposite enantiomers of a small-molecule
target with equal affinity and selectivity to give mirror-image complexes.
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synthesized having orthogonal fluorophores (Figure 2.2a). These enantiomeric sensors  
can then be added together to a solution of the target molecule, and two-color fluores-
cence measurement used to provide the concentration of each enantiomer of the target, 
in turn providing both yield and enantiopurity. We note that upon addition of different 
fluorophores to the D- and L-DNA biosensors, these complexes are no longer perfect 
enantiomers. However, we find that this subtle difference in chemical structure has only 
a minor impact on the performance of the biosensors, and does not alter their ability to 
behave according to the concept of reciprocal chiral substrate selectivity. Thus, while the 
D- and L-DNA biosensors in our study are not true enantiomers, for simplicity we will re-
fer to them as enantiomeric.  
Using the previously reported structure-switching biosensor for L-tyrosinamide 
(L-Tym), (Figure 2.2b)(Table 2.1),39 we demonstrate here the ability to rapidly and accu-
rately measure both enantiopurity and concentration for mixtures of L- and D-Tym.  To 
demonstrate the utility of this approach, we apply our enantiomeric biosensors to the op-
timization of reaction conditions for the synthesis of D-Tym.  We demonstrate that our 
fluorescence-based approach not only allows rapid screening of multiple conditions and 
reaction time-points, but has potential to enable near real-time analysis.  We also pro-
vide mathematical analysis to suggest that structure-switching biosensors having only 
modest binding selectivity can also be used for fluorescence-based enantiopurity meas-
urement.  Together, this research provides a novel method for the high-throughput anal-
ysis of enantiopurity that can be adapted for use with a diverse array of small-molecule 
targets and has potential to enable screening of ~105-106 reaction mixtures per day.  
Achieving this high level of throughput in a generalizable format is anticipated to signifi-
cantly accelerate reaction optimization for the synthesis of high-value chiral small mole-
cules. 
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Figure 2.2.  Biosensor design and target (a) Enantiomeric structure-switching biosen-
sors are functionalized with orthogonal fluorophores, enabling simultaneous quantifica-
tion of both enantiomers of the target molecule. HEX = hexachlorofluorescein; FAM = 
fluorescein. (b) Chemical structures of L- and D-Tym. 
Table 2.1. Sequences of the aptamer and complementary strands tested during biosen-
sor optimization. The underlined region of the aptamer indicates the complementary 
strand binding site. 








To demonstrate the utility of our enantiopurity analysis method, we utilized the 
previously reported DNA aptamer for L-Tym.  This aptamer was first reported by Gatto 
and coworkers in 2001,40 and in 2011, was elaborated into an structure-switching bio-
sensor by Peyrin and coworkers.39 The structure-switching biosensor developed by Pey-
rin was utilized for L-Tym detection by fluorescence polarization (FP), so the aptamer 
was unfunctionalized, and the complementary strand was labeled with a fluorophore. 
For our biosensing format, we instead functionalized the termini of the aptamer and 
complementary strand with a fluorophore and quencher, respectively, to enable small-
molecule quantification using a standard fluorescence plate reader.  
Identifying an appropriate fluorophore pair 
For our orthogonal fluorophores to be used on the D- and L-DNA aptamers, we 
initially chose fluorescein (FAM) and cyanine 3 (Cy3). However, initial results showed 
that the Cy3 biosensor had a Ksens value (defined as the ligand concentration at which 
half of the aptamer strands are dehybridized from their complementary strands) 2-fold 
higher than that of the FAM biosensor. Similar results demonstrating the differential im-
pact of cationic and anionic dyes on aptamer-complementary strand binding have been 
reported by Peyrin and coworkers.39 Therefore, in refining our enantiomeric dual biosen-
sors, we sought to use dyes having similar chemical properties, as this was hypothe-
sized to result in biosensors having similar Ksens values. We found that hexachlorofluo-
rescein (HEX) and FAM were an ideal fluorophore pair for our dual biosensors, as these 
fluorophores have very similar electronic and structural properties, and have excita-
tion/emission maxima of 524/572 nm (HEX) and 490/520 nm (FAM), making them spec-
trally orthogonal.  Furthermore, Black Hole quencher 1 (BHQ1) effectively quenches 
both FAM and HEX, minimizing the difference in chemical modifications. To validate the 
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orthogonality of our fluorescent biosensors, we carried out an experiment in which solu-
tions were prepared having the D-DNA aptamer functionalized with HEX, the L-DNA ap-
tamer functionalized with FAM, or an equal mixture of the two aptamers.  All samples 
were analyzed for fluorescence intensity using excitation/emission wavelengths of 
490/520 nm and 524/572 nm, and we observed significant signal above background for 
each biosensor using its target wavelengths, but no signal was detectible above back-
ground when using the off-target wavelengths (Table 2.2). Thus, we decided to utilize 
HEX-BHQ1 and FAM-BHQ1 as our fluorophore-quencher pairs in all subsequent struc-
ture-switching biosensors.  
Biosensor design and optimization
Our first consideration in biosensor optimization was to screen buffer conditions 
for those that provided the highest selectivity and lowest fluorescence background. We 
used the conditions reported by Peyrin as a starting point for optimization, but found that 
for our assay, a higher ionic strength was beneficial.  This optimized binding buffer (10 
mM Tris-HCl, 100 mM NaCl, 5 mM KCl, 2 mM MgCl2, 1 mM CaCl2, pH 7.5) was used 
for all of the following experiments. 
It is well established that the length and binding position of the complementary 
strand can have a large impact on the hybridization and ligand binding characteristics of 
structure-switching biosensors,41 and a number of complementary strand sequences 
have previously been tested for use with the L-Tym aptamer in CE and FP 
experiments.16, 39  Based upon these previous reports, we synthesized and tested four 
BHQ1-labeled complementary strands having various lengths (Table 2.1).  Each of these 
complementary strands were incubated with HEX-labeled L-Tym (D-DNA) aptamer and 
increasing concentrations of L-Tym. After allowing 20 minutes for equilibration, the per-
cent displacement (%D) for each biosensor was calculated using equation 1.1 in which F 
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is the measured fluorescence, F0 is the fluorescence of the biosensor in the absence of 
ligand, and Fm is the fluorescence of the aptamer alone.  
(Eq 2.1)                                           Ψܦ ൌ ቀ ிିிబி೘ିிబቁ כ ͳͲͲ
We compared %D values for the different complementary strand sequences to de-
termine which sequence provided the greatest signal-to-noise ratio across a wide range 
of ligand concentrations. Of those tested, we found that CS-09 showed the best signal-
to-noise ratio at 25 ⁰C (Figure 2.3).  
The concentrations and stoichiometry of the aptamer and complementary strand 
can also have a dramatic impact on Ksens, as these factors influence the position of equi-
librium for hybridization of the two DNA strands, which is in direct competition with the 
equilibrium of ligand binding.  Therefore, to optimize aptamer and complementary strand 
concentrations and stoichiometry, we first prepared 6 solutions of the D-DNA biosensor 
having a 1:1 aptamer:complementary strand stoichiometry, but having concentrations of 
each strand varying from 30 nM to 1 μM. A binding isotherm for hybridization of the ap-
tamer and complementary strand was produced by plotting the concentration versus 
percent displacement (Figure 2.4).  
At lower concentrations, high background fluorescence was observed, presuma-
bly because equilibrium favors dehybridization of the aptamer and complementary 
strand. However, calculations from our binding isotherm indicated that at 500 nM, ap-
proximately 90% of the aptamer strands were hybridized to a complementary strand. We 
reasoned that this approximate level of hybridization would be suitable for our enantiopu-
rity assay, as the majority of biosensors are assembled, minimizing background and 
maximizing potential signal gain.  However, the presence of a small number of disas-
sembled biosensors suggests that the mixture is perched at an equilibrium where small 
perturbations in the energetics of the system (e.g., through the introduction of target  
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Table 2.2. Demonstrating orthogonality of FAM and HEX. Table shows values for rela-
tive fluorescence intensity. 
excitation/emission wavelength FAM FAM/HEX HEX 
490/520 nm 72589 75052 81 
524/572 nm 228 79944 88050 
Figure 2.3. Complementary strand length strongly impacts the responsiveness of the 
structure-switching biosensor. CS-09 was chosen for all subsequent enantiopurity analy-
sis experiments. 












ligand) are likely to produce large shifts in the ratio of assembled:disassembled biosen-
sors, and thus fluorescence signal.  
In addition to optimizing concentration, we also systematically investigated the ef-
fect of aptamer:complementary strand stoichiometry on signal-to-background ratio. Simi-
lar to overall concentration, varying the stoichiometry of the aptamer and complementary 
strand shifts the equilibrium for assembly of the biosensor, and thus impacts both back-
ground and signal gain. Five samples were prepared having 500 nM aptamer and a 1:1, 
1:1.5, 1:2, 1:2.5, or 1:3 aptamer:complementary strand ratio. Each sample was tested 
with increasing L-Tym concentrations, and we found that the 1:2.5 ratio provided the 
highest level of reproducibility. While 1:1 to 1:2.0 gave greater overall signal response, 
they were found to be less reproducible than 1:2.5 producing higher noise at low target 
concentrations (Figure 2.5). Thus, we identified 500 nM aptamer and 1.25 μM comple-
mentary strand as the ideal concentrations for use in our enantiopurity assays. 
Enantioselectivity and specificity of biosensors 
Having optimized the sequences and concentrations of the structure-switching 
biosensors, we next turned to analyzing target binding selectivity.  First, the biosensors 
were individually tested for binding to L- and D-Tym. The data in Figure 2.6a-b illustrate 
that the biosensors bind to Tym with a high degree of enantioselectivity, as fluorescence 
signal was observed for the target enantiomer at concentrations as low as 3-10 μM, but 
no binding of the off-target enantiomer was detected up to 1 mM. To test the effect of 
side chain structure on aptamer binding, glycinamide (Glm), racemic alaninamide (Alm), 
and both L- and D-phenylalaninamide (L-Phm and D-Phm) were incubated with the bio-
sensors and fluorescence intensity measured (Figure 2.6c-d). Glm and Alm were chosen 
because they are the least-functionalized non-chiral and chiral amino amides, respec-
tively.  Thus, binding information for these molecules would reveal the role of the phenyl 
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side chain and chiral center in aptamer recognition. No signal was observed for either of 
these targets at concentrations up to 1 mM, suggesting that the phenyl side chain is crit-
ical to aptamer binding. In contrast, L- and D-Phm were found to bind enantioselectively 
to the structure-switching biosensors, showing a similar trend to L- and D-Tym, but with 
a weaker binding affinity. We interpret this result to indicate that the hydroxyl functionality 
of Tym likely interacts with the aptamer via a hydrogen bonding interaction, and that this 
interaction strengthens, but is not critical to target binding.  Finally, the importance of the 
amino amide functionality was investigated using L- and D-tyrosine ethyl ester (L-Tyr-
OEt and D-Tyr-OEt). As selectivity for Tym over Tyr-OEt is necessary for the reaction 
monitoring experiments described below, we were pleased to observe no signal for L- or 
D-Tyr-OEt at concentrations up to 1 mM. Collectively, these data indicate that the chirali-
ty, phenyl side chain, and amide functionality all play critical roles in binding of the ap-
tamer to the target, and the presence of a hydroxyl group on the phenyl ring enhances 
the strength of the aptamer-target binding interaction.  
In principle, enantiomeric D- and L-DNA biosensors should bind to opposite en-
antiomers of a given small-molecule target with identical Ksens values.  However, the data 
in Figure 2.6 show that the L-DNA biosensor consistently gives slightly smaller % dis-
placement values compared to the D-DNA biosensor.  
 We hypothesize that this difference arises from the fact that our biosensors are 
not perfectly enantiomeric. The FAM and HEX fluorophores, while carefully selected, 
have different electronic properties, which can impact binding of the aptamer to the dis-
placement strand, leading to differences in target-dependent displacement. However, it 
is important to note that we use calibration curves as described below to solve for the 
concentration of each enantiomer. Thus, these subtle differences in biosensor response 
will not impact the accuracy of our enantiopurity measurements. 
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Figure 2.6. Fluorescence response of (a) D-DNA and (b) L-DNA biosensors to L- and D-
Tym.  Fluorescence response of (c) D-DNA and (d) L-DNA biosensors to structurally re-

















Enantiopurity analysis for mixtures of L- and D-Tym 
As seen in Figure 2.6a-b, the fluorescence response of the structure-switching 
biosensors follows a Langmuir isotherm. This is to be expected, as the fluorescence sig-
nal results from an equilibrium binding interaction between the aptamer and the target.  
Thus, we reasoned that by maintaining substrate concentrations below saturation, we 
could construct calibration curves to enable quantitative analysis of unknown samples.  
Importantly, the use of % displacement instead of raw fluorescence intensity enables the 
calibration curve to be applied across samples analyzed on different days and potentially 
on different pieces of instrumentation.  
To construct the calibration curves, the L- and D-DNA biosensors were combined 
together in a single solution and incubated with varying concentrations of L- and D-Tym. 
In each solution, the total Tym concentration was held at constant at 500 μM, and the 
D:L ratio of the Tym was systematically varied from 100:0 to 0:100. Each solution was 
analyzed using excitation/emission wavelengths of 490/520 nm and 524/572 nm to de-
termine % displacement of the FAM and HEX biosensors, respectively (Figure 2.7a). We 
were encouraged to observe that in both of the solutions containing only a single enanti-
omer of Tym (0 and 100% L-Tym in Figure 2.7a), the off-target biosensor showed no de-
tectable signal.  This further validates the excellent binding selectivity of the aptamer and 
the lack of fluorescence cross-talk between the FAM and HEX fluorophores. The result-
ing calibration curves were each fit to a Langmuir binding isotherm using OriginPro. The 
Ksens values for the D- and L-DNA structure-switching biosensors were calculated to be 
442 ± 28 μM and 464 ± 29 μM, respectively. These values are significantly higher than 
the Ksens of 160 μM reported for the Peyrin fluorescence polarization biosensor, likely 
due to the higher ionic strength of the binding buffer used in our experiments. However, 
given our proposed application of organic reaction monitoring, where typical substrate 




Figure 2.7. Dual biosensor results (a) Enantiopurity analysis of samples having varying 
ratios of L/D-Tym.  All samples had a total Tym concentration of 500 μM. Curves were fit 
to langmuir isotherms. Equations and R2 values can be found in Appendix A. (b) Com-
parison of calculated vs actual % L-Tym. 
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not anticipated to be problematic. 
To test the accuracy of our calibration curve fitting, we used the resulting Lang-
muir equation to independently calculate the % L for each Tym mixture.  Figure 2.7b 
compares the calculated vs. actual values of % L-Tym. The deviation between calculated 
and actual values of % L-Tym ranged from 0-2.2%, with an average deviation of 0.66%. 
The error bars on each measurement are calculated from the standard deviation of 3 
independent fluorescence experiments, and range from 0.17-1.64% with an average er-
ror of 0.71%. Together, these data establish a high level of accuracy and reproducibility 
for our enantiopurity analysis method. 
Analysis of reaction conditions and progress 
To validate the utility of our enantiopurity analysis method, we chose to apply it to 
optimization and monitoring of the synthesis of Tym from Tyr-OEt.  The importance of 
reaction optimization for this particular transformation became apparent during our initial 
experiments using the Tym biosensors.  We had set out to synthesize D-Tym using a 
literature protocol, but observed anomalous results when our “D-Tym” was tested with 
the structure-switching biosensors.  Analysis of our small-molecule product using chiral 
chromatography revealed that a significant degree of racemization had occurred using 
the reaction conditions reported in the literature (stirring in NH4OH for 48 hours at 4 
⁰C).42  We hypothesized that this racemization could be suppressed by reducing reaction 
time, but this would come with the trade-off of reduced yields, and thus optimization 
would be of high utility. 
One unique benefit of calculating enantiopurity from the absolute concentration of 
each enantiomer is that it also enables simultaneous monitoring of reaction yield. More-
over, our method requires only that a sample from a reaction mixture be diluted into 
buffer containing the enantiomeric structure-switching biosensors, incubated to allow for  
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equilibration, and analyzed on a fluorescence plate reader.  In our experiments, these 
manipulations required approximately 25 minutes, but this time could likely be signifi-
cantly reduced by shortening the equilibration period. Thus, our method has potential to 
allow for near real-time monitoring of reaction mixtures. 
To demonstrate the utility of our biosensors for monitoring the conversion of D-
Tyr-OEt to D-Tym, we reacted D-Tyr-OEt with ammonium hydroxide at four temperatures 
ranging from 10-50 °C.  While these temperatures are higher than those in the initially 
reported literature conditions, we reasoned that these conditions warranted investigation, 
as it was possible that racemization could be minimized by utilizing shorter reaction 
times, without negatively impacting yield. For each reaction, 100 μL aliquots were re-
moved at 16 time points over the course of 2 hours, diluted to 10 mL with binding buffer 
containing both structure-switching biosensors, and analyzed using a fluorescence plate 
reader. The % displacement was calculated for each biosensor, and these values were 
used to independently solve for the concentration of each enantiomer of Tym using our 
calibration curves.   
A plot of the % yield of each enantiomer as a function or time for each of our four 
reaction temperatures is shown in Figure 2.8. These data reveal that while increasing 
the temperature of the reaction increases the rate of product formation, it also increases 
the rate of epimerization. However, by reducing the reaction temperature to 10 ⁰C, D-
Tym can be generated in modest, though reasonable, yield with no observable epimeri-
zation after 2 hours.  
To validate the accuracy of our enantiopurity measurements, we employed chiral 
HPLC to analyze all of the samples from the reaction carried out at 50 ⁰C.  We initially 
attempted to identify HPLC conditions that would enable baseline resolution of L- and D-
Tym, but despite surveying a large number of solvent systems with multiple chiral col-
umns, we were unable to achieve sufficient resolution.  However, we were able to 
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Figure 2.8. Monitoring the yield of D- and L-Tym during reaction of D-Tyr-OEt with am-
monium hydroxide at (a) 10 oC, (b) 20 oC, (c) 30 oC, and (d) 50 oC. 
31
achieve good resolution of L- and D-Tyr.  Thus, we first used HPLC to separate all Tym 
from Tyr-OEt, then hydrolyzed the Tym to Tyr using H-form Dowex for 24 hours at 100 
⁰C. Finally, we were able to determine the ratio of L- and D-Tyr using an Astec Chirobi-
otic T 25 cm X 4.6 mm, 5 μm column. To ensure that no racemization occurred during 
the hydrolysis, we tested this protocol using a mixture L/D-Tym containing 10% L enanti-
omer, and measured 9.98% L-Tyr in the final HPLC. The data in Table 2.3 compare the 
% L-Tym for the reaction samples as measured by HPLC and using the biosensors, and 
show an average difference of 1.5% L-Tym, thus validating the accuracy of our reaction 
monitoring experiments.  
We highlight that analysis of all of the samples in our study required approxi-
mately 1 minute of scanning on a plate reader when using our fluorescent biosensors, 
but would have required approximately 17 hours using chiral HPLC, even without the 
additional hydrolysis and manipulations required specifically for Tym. Thus, this initial 
reaction monitoring study demonstrates that we can rapidly generate data regarding 
both yield and enantiopurity for multiple reaction conditions, and that these data can be 
used to identify optimized conditions for a synthetic transformation in significantly less 
time than would be required using HPLC.  
Enantiopurity analysis using structure-switching biosensors 
having moderate enantioselectivity
The extremely high enantioselectivity of the Tym structure-switching biosensor 
enables quantification of individual enantiomers of the target with negligible off-target 
signal. However, not all aptamers possess such high enantioselectivity, and thus we 
sought to develop a mathematical model that would enable the measurement of enanti-
opurity using structure-switching biosensors that have only moderate enantioselectivity. 
Figure 2.9 shows a calculated representation of the signal that would be observed for  
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Table 2.3. Validation of reaction monitoring results using HPLC.  Samples were utilized 
from the 50 oC reaction.  
Time (min) % L-Tym (biosen-sors) % L-Tyr (HPLC) deviation 
6 6.9 10.3 3.5 
8 9.7 4.9 4.8 
10 10.2 7.6 2.6 
20 6.9 4.6 2.2 
30 13.1 11.0 2.1 
40 8.9 7.1 1.7 
50 6.3 5.3 1.0 
60 6.2 5.0 1.3 
70 5.2 3.7 1.5 
90 7.0 5.7 1.3 
100 8.4 6.8 1.5 
Figure 2.9. Modeling of fluorescence signal arising from a combination of on-target and 
off-target binding interactions. 
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enantiomeric structure-switching biosensors that bind to a target with 100:1 enantiose-
lectivity.  In this graph, the dotted lines represent signal arising from each of the biosen-
sors binding to its target enantiomer, and the dashed lines represent signal arising from 
the off-target enantiomer.  The solid line is the sum of these two signals and represents 
the total relative fluorescence intensity that would be observed for each of the biosen-
sors (FD and FL). The values of FD and FL can be used in equation 2.2 to solve for small-
molecule enantiopurity.   
As shown in Figure 2.10, K1 and K2 are the on-target and off-target Ksens values, 
respectively, for the L-DNA biosensor, and K4 and K3 are the on-target and off-target 
Ksens values, respectively, for the D-DNA biosensor (specific pairing of the D- and L-DNA 
biosensors with S- and R-enantiomers of target was arbitrarily chosen for this model). 
These values can be obtained empirically by measuring the fluorescence response of 
each biosensor with varying concentrations of each ligand, then fitting these data to the 
Langmuir equation. Atot is the total aptamer biosensor concentration. Using this equation, 
the ratio of enantiomers in a mixture can be determined even if a significant (ca. 1%) 
amount of off-target binding is observed.  The primary limitation to this alternative calcu-
lation method is that it can only provide a ratio of the two enantiomers, and not their total 
concentration. To determine the concentrations of the two enantiomers, equation 2.3 can 
be used. Equation 2.3 requires the creation of a calibration curve relating absolute fluo-
rescence of each enantiomer to concentration. The use of these two equations greatly 
increases the flexibility of this system. 
Derivation of equation 2.2 for enantiopurity analysis using 
aptamers having moderate selectivity
Key: 






Figure 2.10. Equilibria involved in on-target and off-target interactions.  Specific pairing 
of the D- and L-DNA biosensors with S- and R-enantiomers of target was arbitrarily cho-






AD= D-DNA aptamer biosensor 
Atot= Total aptamer biosensor 
Ri= Initial R-enantiomer 
Si= Initial S-enantiomer 
R·A= R-enantiomer bound to aptamer biosensor 
S·A= S-enantiomer bound to aptamer biosensor 
FL= Total fluorescence from L-DNA biosensor 
FD= Total fluorescence from D-DNA biosensor 
 
Given the mechanism below for binding of D- and L-DNA biosensors to S- and R-
enantiomer of target: 
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Given that aptamer may exist free, or bound to either enantiomer of target: 
ሾ୲୭୲୐ ሿ ൌ ሾ୐ሿ ൅ ሾ ή ୐ሿ ൅ ሾ ή ୐ሿ
ሾ୲୭୲ୈ ሿ ൌ ሾୈሿ ൅ ሾ ή ୈሿ ൅ ሾ ή ୈሿ
Then substituting for the concentration of aptamer-target complexes gives: 
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ሾ୲୭୲୐ ሿ ൌ ሾ୐ሿ ൅ ଶሾሿሾ୐ሿ ൅ ଵሾሿሾ୐ሿ
ሾ୲୭୲ୈ ሿ ൌ ሾୈሿ ൅ ସሾሿሾୈሿ ൅ ଷሾሿሾୈሿ
Using an excess of ligand, complex arising from off-target binding is negligible compared 
to total target, and thus: 
ሾሿ ൎ ሾ୧ሿ െ ሾ ή ୈሿ
ሾሿ ൎ ሾ୧ሿ െ ሾ ή ୐ሿ
Substituting for [R] and [S] and factoring out [A] gives: 
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Solving for [Ri] and [Si] gives: 
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Substituting [Ri] and [Si] into one another allows for both equations to be expressed in 
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Recalling that: 
ሾ୐ሿ ൌ ሾ୲୭୲୐ ሿ െ ሾ ή ୐ሿ െ ሾ ή ୐ሿ
ሾୈሿ ൌ ሾ୲୭୲ୈ ሿ െ ሾ ή ୈሿ െ ሾ ή ୈሿ
and that total fluorescence is representative of the sum of on-target and off-target inter-
actions for a given aptamer, the following equations can be generated in which x and y 
are scaling factors relating concentration to relative fluorescence intensity. The values of 
x and y can be experimentally determined using a calibration curve. 
ሾ ή ୐ሿ ൅ ሾ ή ୐ሿ ൌ ݔ	୐
ሾ ή ୈሿ ൅ ሾ ή ୈሿ ൌ ݕ	ୈ
Following the earlier assumption that the off-target contribution to the signal is negligible 
compared to on-target: 
ሾ ή ୐ሿ ൎ ݔ	୐
ሾ ή ୈሿ ൎ ݕ	ୈ
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Substitution of fluorescence intensity in place of concentrations for aptamer-target com-
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Derivation of equation 2.3 for enantiopurity analysis using 
aptamers having moderate selectivity
Key: 
Ri= Initial R-enantiomer 
Si= Initial S-enantiomer 
FL= Total fluorescence from L-DNA biosensor 
ܨ௅ௌ= Total fluorescence from L-DNA biosensor from S-enantiomer 
ܨ௅ோ= Total fluorescence from L-DNA biosensor from R-enantiomer 
FD= Total fluorescence from D-DNA biosensor 
ܨ஽ௌ= Total fluorescence from D-DNA biosensor from S-enantiomer 
ܨ஽ோ= Total fluorescence from L-DNA biosensor from R-enantiomer 
 
Each signal can be represented by the following components: 
ܨ௅ௌ ൌ
ሾ ௜ܵሿ
ܭଵ ൅ ሾ ௜ܵሿ
Ǣ  ܨ஽ௌ ൌ
ሾ ௜ܵሿ









Therefore the total signal of the L and D biosensors can be expressed as: 
ܨ௅ ൌ
ሾ ௜ܵሿ
ܭଵ ൅ ሾ ௜ܵሿ
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Rearrangement gives the following two linear equations: 
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In summary, we describe here a novel method for the rapid and high-throughput 
analysis of both small-molecule concentration and enantiopurity.  This method relies on 
the ability of structure-switching nucleic acid biosensors to transduce the presence of a 
small-molecule target into a dose-dependent fluorescence output, and the ability of en-
antiomeric structure-switching biosensors to simultaneously quantify both enantiomers of 
the target molecule. Using our enantiomeric biosensors, we demonstrate the ability to 
measure the % L-enantiomer in a genuine reaction mixture with an average error of 
1.5% relative to values determined by HPLC analysis.  Additionally, we demonstrate the 
utility of our method by applying it towards optimization of reaction conditions for the syn-
thesis of D-Tym.  Finally, we have generated a mathematical model to demonstrate that 
enantiopurity analysis is also feasible using aptamer biosensors that possess only mod-
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erate enantioselectivity. 
Our initial demonstration of this enantiopurity analysis method required significant 
optimization of the structure-switching biosensor concentration and stoichiometry, as 
well as identification of the ideal range of target concentrations.  However, with the 
knowledge gained from these experiments, these optimizations could be rapidly per-
formed on a new aptamer system, enabling use of our method to analyze the enantiopu-
rity of a wide range of potential small-molecule targets. Fluorescence-based measure-
ment techniques such as the one described here have potential to enable orders-of-
magnitude higher throughput relative to the standard HPLC analysis methods. Thus, we 
envision that enantiomeric aptamer-based sensors will prove to be a powerful tool for the 
high-throughput analysis of reaction outcomes, enabling rapid optimization of reaction. 
 Materials and Methods
General methods
 Unless otherwise noted, all starting materials were obtained from commercial 
suppliers and used without further purification. All DNA was purchased from the Universi-
ty of Utah DNA/Peptide Synthesis Core Facility. All absorbance and fluorescence values 
were recorded using a Biotek Synergy Mx microplate reader.
Modifiers used for DNA synthesis
Fluorescein and hexachlorofluroscein dyes were installed using phospho-
ramidites from Glen Research. Black Hole quencher 1 was installed using CPG cartridg-
es from Glen Research.  L-DNA was prepared using phosphoramidites from 
ChemGenes.  
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Preparation of biosensor stocks
Binding buffer (10 mM Tris-HCl, 100 mM NaCl, 5 mM KCl, 2 mM MgCl2, 1 mM 
CaCl2, pH 7.5) was used for all DNA stock solutions. DNA biosensors were prepared by 
generating a solution containing 1 μM aptamer and 2.5 μM complementary strand in 
binding buffer. This solution was incubated at 90 °C for 10 minutes then rapidly cooled 
and stored at 4 °C. Prior to use, the solution was allowed to warm to room temperature.  
Enantiopurity measurement
A sample of 50 μL containing varying concentrations of L- and D-Tym was com-
bined with 50 μL of the biosensor stock solution described above to give a 100 μL sam-
ple having concentrations of 500 nM aptamer and 1.25 μM complementary strand. 
These samples were then transferred to a Costar 96-well black flat bottom polystyrene 
plate. The plates were covered and incubated at 25 °C for 20 minutes and subsequently 
scanned for fluorescence intensity using excitation/emission wavelengths of 490/520 nm 
(FAM) and 524/572 nm (HEX). Fluorescence values were standardized using a control 
solution containing only fluorophore-labeled aptamer. 
Reaction progress
All reactions were carried out in 200 μL PCR tubes using a Bio-Rad PTC-1148 
thermocycler for temperature control. D-tyrosine ethyl ester was added to 100 μL of 
NH4OH to a final concentration of 10 mM. Reactions were quenched by diluting the reac-
tion mixture into of 9.9 mL of binding buffer containing the biosensors at specified time 
points. Samples were then analyzed as described above. 
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HPLC validation 
We were unable to achieve baseline separation of L- and D-Tym using a com-
mercially available HPLC column, and thus, we developed the following method for puri-
fication, hydrolysis, and analysis of our reaction mixtures. Samples from the reaction car-
ried out at 50 °C were lyophilized and desalted. The L/D-Tym was separated from the 
remaining unreacted Tyr-OEt by HPLC using 60:40 water:MeOH (Agilent ZORBAX 
Eclipse XDB-C18, 5 μm, 9.4 x 250 mm). Collected fractions were lyophilized and re-
suspended in 100 μL water. The solutions were then added to H-form Dowex and react-
ed for 24 hours at 100 °C to hydrolyze the tyrosinamide to tyrosine. Dowex was removed 
using 0.2 μm centrifuge spin filters (Millipore UFC30GV00) and the L/D-Tyr was purified 
by HPLC using 60:40 water:MeOH (Agilent ZORBAX Eclipse XDB-C18, 5 μm, 9.4 x 250 
mm). The Tyr fraction was then analyzed by chiral HPLC (Astec Chirobiotic T 25 cm x 
4.6 mm) using 20:80 water:MeOH with 0.02% formic acid. Enantiomeric ratios were cal-
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SELECTION OF APTAMER BIOSENSORS FOR THE HIGH-THROUGHPUT
SCREENING OF ENZYME-MEDIATED REACTIONS
Introduction 
Enzymes provide an excellent example of the power of natural selection, as they 
are capable of catalyzing nearly all of the chemical reactions needed for life, ranging 
from highly complex syntheses to simple modifications of small molecules.1 At the inter-
face between chemistry and biology lies a field termed chemical biology, in which scien-
tists often try to mimic nature’s designs. Harnessing some of nature’s power can pro-
duce far better catalysts than could be created in the laboratory. Unfortunately, natural 
enzymes cannot catalyze as many exotic reactions as synthetic catalysts can. However, 
inspired by the power of evolution, in vitro selection can be used to improve natural en-
zymes and even create new ones. Using techniques such as saturation mutagenesis 
and error-prone PCR, scientists are evolving exciting new enzymes having extremely 
high selectivity and specificity. 2-4 
Enzymes from the Cytochrome P450 monooxygenases (P450) superfamily have 
been gaining popularity as efficient and environmentally friendly catalysts for organic 
synthesis.5 These heme-containing enzymes can facilitate a broad range of reactions, 
and typically have high regioselectivity and stereoselectivity. P450 enzymes are found in 
all domains of life and are used for the detoxification of many drugs, accounting for al-
most 75% of all metabolic reactions related to bio-activation and drug metabolism.6 Most 
importantly, they are highly tolerant of mutations within the active site, greatly expanding 
the possible substrate scope.7-9 Recent results by Zhao and co-workers have demon-
strated that a single mutation within the active site of a wild-type P450 could invert enan-
tioselectivity from the S-enantiomer to the R-enantiomer with 42% enantiomeric excess 
(ee).10 Further modifications led to an increased R-enantioselectivity of 83% ee. This 
was found via individual randomization of 17 amino acids through site-saturation muta-
genesis.  Arnold and co-workers reported that a variant of P450 BM-3 could be evolved 
through site-saturation mutagenesis to perform enantioselective hydroxylation at the al-
pha position of small aromatic compounds.9 Later work demonstrated that a single modi-
fication at phenylalanine 87 (F87) of this P450 BM-3 variant was capable of increasing 
reactivity nearly 10-fold.11 Developing enzyme libraries has become increasingly facile 
due to new techniques in directed evolution,12 and the limitations now lie in screening the 
enormous enzyme libraries produced.13-14 
The probability of discovering novel or improved enzymes using directed evolu-
tion increases with library size. However, the amount of time required to screen a library 
also greatly increases with size, making library screening a limiting factor in enzyme dis-
covery. Sequence space can be defined mathematically as N = ଵଽ
ಾ௑Ǩ
ሺ௑ିெሻǨெǨ, where X repre-
sents the total residues in the enzyme, N the maximum theoretical diversity, and M the 
total number of mutations.15 An enzyme library where twenty amino acids are randomly 
mutated would produce a library of ~1026 potential sequences. As a result, screening 
efficiency dictates the maximum number of sites that can be randomized, and must be 
taken into account when designing libraries.1 The most recent, and currently most pow-
erful screening method utilizes mass spectrometry to determine the ee of a given reac-
tion. This method has the ability to screen thousands of samples daily, greatly increasing 
the enzyme sequence space that can be covered. Unfortunately, this method is limited 
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to a small subset of molecules, usually requires isotopic labeling, and would still require 
months to scan the potential sequence space created by five random mutations. Chapter 
2 of this dissertation introduced an alternative method using nucleic acid biosensors to 
create a high-throughput screening method that has the potential to screen up to one 
million samples per day.  
Aptamers are nucleic acid sequences that are capable of binding to a variety of 
small-molecule and protein targets. They have been adapted for use in a wide variety of 
tasks throughout chemistry and biology. Aptamers have emerged as a promising alter-
native to antibodies as they show little batch-to-batch variation and can be engineered 
through an in vitro selection process called Systematic Evolution of Ligands by EXpo-
nential Enrichment (SELEX) (Figure 3.1).16-17 Using SELEX, aptamers can be selected to 
discriminate between ligands that are structurally similar. They can also bind to a diverse 
range of ligands with micromolar to nanomolar dissociation constants (Kd), making them 
well-suited for the creation of biosensors.  DNA aptamers generally have tertiary struc-
tures with a variety of stems and loops. Using structure prediction software such as 
Mfold18, it is possible to hypothesize where the binding site may be, allowing for a dis-
placement strand to be designed, allowing for the construction of a structure-switching 
biosensor. The majority of structure-switching biosensors have been described in depth 
by Lu and coworkers (Figure 3.2).19 However, the vast majority of aptamers do not have 
the privilaged architeture required to allow for target-responsive displacement. As such, 
the overarching goal of the research described in this chapter is to develop an efficient 
method for selecting enantioselective small-molecule-binding aptamers that can function 






Figure 3.1. SELEX allows for the enrichment of randomized libraries to perform selected 
functions. Modified primers are used for quantification and separation of sense and anti-
sense strands to complete each round. 
 
Figure 3.2. Structure-switching biosensor. Aptamer and displacement strand are shown 
in green and purple, respectively. Upon incubation with the target molecule, the aptamer 
binds and displaces the displacement strand. 
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Results and Discussion
Selecting an enantioselective aptamer for the small molecule
(S)-2-chloromandelic acid
The research in this chapter explores a variety of methods for generating DNA 
aptamers and biosensors to the small molecule 2-chloromandelic acid (2-CMA) (Figure 
3.3). This target was chosen because 2-CMA is an intermediate for the blockbuster cho-
lesterol-lowering drug clopidogrel (Plavix).19 The stereocenter at the alpha position of 2-
CMA can be set through an enzyme catalyzed reaction, which would allow for the ap-
tamer that is selected to be used for enzyme screening. Currently, the best enzyme can 
only confer an ee of 82%. We hypothesized that through the use of our enantioselective 
high-throughput screening method, we could greatly increase the number of mutants 
screened and therefore find an enzyme capable of producing higher enantiopurity. 
FluMag-SELEX with immobilized target
SELEX produces aptamer sequences via multiple rounds of selection from a 
random library of oligonucleotides. The FluMag method for SELEX was chosen as the 
starting point for the design of this experiment as it relies on the convenient attachment 
of the small molecule of interest to magnetic beads.20 (S)-2-chloromandelic acid ((S)-
CMA) was used to create a synthetic analog to allow for attachment to the magnetic 
beads (Scheme 3.1).  
Six nmols (~1015 sequences) of a DNA library consiting of 40 random nucleotides 
flanked by primer binding sites was used to begin SELEX. Subsequent rounds used 
approximately 200 pmols of DNA from the previous round. The (S)-CMA analog was 
attached to amine functionalized magnetic beads, and was incubated with the library. 












Scheme 3.1. Synthesis of a (S)-2-chloromandelic acid adduct for magnetic bead at-
tachment. This route allowed for the retention of stereochemistry at the benzylic carbon. 
Attachment through the hydroxyl group was anticipated to allow for greater specificity in 
selections by retaining the pi-stacking ability of the ring. Reductive amination was used 






members, followed by incubation with free (S)-CMA to elute any potential aptamers. 
Quantification of the percent library bound for each round was measured via absorbance 
at 260 nm and cyanine 3 (Cy3) fluorescence emmision at 570 nm (Figure 3.4).  The 
eluted DNA was amplified using the polymerase chain reaction (PCR) with modified 
primers. The forward primer contained a polyethylene glycol (PEG) linker and an A20 
extension, and the reverse primer contained a Cy3 fluorophore. This allowed for 
separation of the double stranded DNA via denaturing polyacrylamide gel 
electrophoresis (PAGE). The DNA bands corresponding to the single stranded DNA 
library were cut out and recovered for use in the next round. Negative selections were 
performed against nonfunctionalized beads before rounds 5 and 9 to remove any library 
members that nonspecifically bound to the beads.  
After twelve rounds, the pool of DNA was highly enriched with sequences that 
bound tightly to the small molecule. The library was then amplified using nonmodified 
primers and inserted into TOP 10 competent E. coli cells using a TOPO cloning kit. 
These were plated on LB/agar plates and incubated overnight. Eight successful colonies 
were chosen and grown overnight in enriched media. The cells were lysed and the 
plasmid DNA was recovered and sequenced at the University of Utah DNA sequencing 
core facility. Using Multalign free software, all sequences were aligned and the three 
with the highest level of conserved regions were selected (Figure 3.5). Competitive 
elution experiments provided the best method of studying the binding affinity for the 
aptamers. It was determined that of the three aptamers, aptamer 2.2 had the greatest 
affinity for (S)-CMA. Using structural predictions from Mfold, we minimized the sequence 
of aptamer 2.2 from 76 bases to 55 (2.2t) (Figure 3.6). 2.2t retained the main series of 
stem loops that existed in the most stable Mfold structure of the original 76mer. 2.2t was 









Figure 3.5. Alignment of sequences from round 12. Sequence 1, 2.2, and 2.4 were se-




Figure 3.6. Mfold predicted structure of aptamer 2.2 was used to minimize the sequence 
to aptamer 2.2t.   
 
 
functionalized beads, and three structurally similar control molecules (Figure 3.7). While 
aptamer 2.2t only shows modest enantioselectivity, this was not suprising as no negative 
selections against (R)-CMA were preformed. However, we were encouraged to see that 
aptamer 2.2 did not bind significantly to any of the structurally similar molecules. 
Determining whether a superior aptamer can be selected through
the use of a biased library or a random library with
stringent negative selections
Using aptamer 2.2t, we explored the possibility of increasing enantioselectivity 
through the use of a biased library and a series of negative selections against (R)-CMA. 
Aptamer 2.2t was used as the starting point to create a biased library for use in the se-
lections. Using Mfold to create structural predictions, six bases were chosen that were 
believed to be possibly the ligand binding sites. A biased library was synthesized by 
placing a 70% bias on the original base and 10% on each of the other 3 bases during 














using the newly created biased library and the other using the DNA pool from round 4 of 
the original FluMag-SELEX experiment.  
 A negative selection method for increasing the enantioselectivity of selected ap-
tamers was also tested. In the final 4 rounds, the aptamer library was heat denatured (70 
⁰C), (R)-CMA was added to a concentration of 100 μM, and then the solution was cooled 
to allow the DNA to refold. Next, the beads were washed thoroughly, and bound DNA 
sequences heat eluted as before. This allowed for the removal of sequences that bound 
more strongly to the (R)-CMA than (S)-CMA.  
After 8 rounds, sufficient enrichment was seen for both the biased and random li-
braries (Figure 3.9). Both libraries were cloned and sequenced using the previously de-
scribed methods. Using Multalign free software, all sequences were aligned and 
grouped into families (Figure 3.10). One sequence from each family was selected for 
further testing. Competitive elution experiments again provided the best method of 
studying the binding affinity and selectivity of the aptamers. It was determined that ap-
tamer BH6 showed the best binding characteristics. Aptamer BH6 was minimized using 
Mfold to give BH6t (Figure 3.11). Competitive elutions were performed on BH6t using 
(S)-CMA, (R)-CMA, nonfunctionalized beads, and one structurally similar molecule 2-
chlorophenyl acetic acid (CAA). It can be seen that BH6t not only binds tightly to (S)-
CMA but also shows very high enantioselectivity and specificity against (R)-CMA and 
CAA (Figure 3.12). The high level of selectivity of BH6t speaks to the power of negative 
selections in the SELEX process. It is interesting to note that while aptamer BH6t was 
selected form the biased library, it showed no structural similarities to aptamer 2.2t. This 
suggests that there is no benefit to beginning with a structurally biased library, as nature 









Figure 3.10. Alignment of sequences after 8 rounds of selections. Alignment was creat-
ed using the free online software Multalign. Blue and red bases show 70% and 100% 
conservation, respectively. Sequences emerging from the biased and random libraries 




Figure 3.11. Mfold predicted structure of aptamer BH6 was used to minimize the se-




Figure 3.12. Competitive elution experiment with aptamer BH6t. 
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Aptamer BH6t conversion to a biosensor
In order to design a structure-switching aptamer biosensor, a displacement 
strand must be created. The displacement strand needs to be in close proximity to the 
active site so that it can be displaced upon ligand binding. However, it must not disrupt 
the function of the binding site. We designed a series of displacement strands based on 
proposed active sites deduced from Mfold. Varying lengths and invasion positions were 
tested for structure-switching function. Unfortunately, after exhausting all of these op-
tions, it was determined that aptamer BH6t would not function as a structure-switching 
biosensor. This highlighted the necessity for the development of better methods to di-
rectly select aptamers with the privileged architecture required for use as structure-
switching biosensors.  
 
Methods for the direct selection of structure-switching biosensors
In response to the difficulties that we encountered in engineering structure-
switching biosensors from aptamers, we began to explore SELEX methods that would 
allow for the direct selection of aptamers that have the desired structure-switching capa-
bilities. One such method developed by the Strehlitz lab,21 Capture-SELEX, utilizes a 
special library that contains a constant docking sequence within the randomized region 
of the library. This docking sequence is complementary to a docking strand that is at-
tached to magnetic beads via a streptavidin-biotin interaction. This design allows for se-
lection using free ligand as opposed to selecting for bead-bound target adducts. Upon 
incubation with the target, sequences that displace from the docking strand can be col-
lected through magnetic separation. Importantly, this directly selects for the structure-
switching architecture we desire, as upon target binding, only those sequences that re-
lease from the docking strand are isolated. However, all of the known structure-switching 
SELEX methods have been performed with larger targets with many functional handles, 
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e.g. aminoglycosides. Our lab wanted to test whether these methods could be used to 
select for more difficult small molecules such as (S)-CMA.  
 
Structure-switching SELEX Trial 1
We began selections for (S)-CMA using the identical sequence and procedure 
outlined by the Stehlitz group.21  M-270 streptavidin beads were conjugated with 3’ biotin 
labeled capture strands. For the first round, 2.5 nmols of library was annealed to the 
capture strand labeled beads. This was accomplished through a snap cool of the library 
followed by a 3-hour incubation at room temperature with nutation. The beads were 
thoroughly washed until background elution was constant. Negative selections for the 
(R)-CMA were performed for every round in an attempt to select only highly enantiose-
lective aptamers. This was accomplished by incubation of the library bound beads with 
1mM (R)-CMA for 30 minutes at room temperature with gentle nutation. The beads were 
then washed and incubated with 1mM (S)-CMA for 30 minutes with gentle nutation fol-
lowed by collection of the supernatant. Sequences eluted in the positive selections were 
PCR amplified, strand separated by denaturing PAGE, extracted, and incubated with 
fresh capture strand labeled magnetic beads to begin the next round. This process was 
carried out through 8 rounds, at which point enrichment was observed.  
Following round 8, we chose to further increase the stringency of selections by 
decreasing the concentration of positive target until we once again observed enrichment. 
We hypothesized that this would allow for enrichment of only the strongest binding ap-
tamers. The (S)-CMA elutions were lowered to 10 μM (S)-CMA while the negative (R)-
CMA elutions remained at 1 mM. Once enrichment was seen, an additional negative se-
lection using 1 mM acetic acid was introduced (Figure 3.13). This negative selection was 
used to remove any aptamers that were simply binding to the acid moiety instead of con-




Figure 3.13. Enrichment of library for trial 1 of structure-switching SELEX. 
 
 
cloned using a TOP 10 competent E. coli cell line. The resulting plasmids were sent for 
Sanger sequencing and sequences were grouped into families using Multialin (Figure 
3.14).  
 A total of 4 sequences were chosen for further testing. The sequences repre-
sented each of the four major consensus families from Multialin. The ligand dependent 
displacement was tested for each sequence by annealing the FAM labeled aptamer se-
quence with BHQ1 functionalized capture strand, resulting in a quenching of the FAM 
signal. Upon incubation with (S)-CMA, any sequences that undergo a structural change 
to displace the capture strand would exhibit a large increase in the FAM signal. Howev-
er, it was found that none of the eight sequences provided substantial fluorescence re-
covery upon exposure to up to 1 mM (S)-CMA. We hypothesized that stringency of the 
selections may have been too high, leading to enrichment of sequences based on fac-
tors other than affinity to (S)-CMA.  




























Figure 3.14. Sequence alignment after 14 rounds of selections. Alignment was created 
using the free online software Multalign. Blue and red bases show 70% and 100% con-
servation, respectively. Highlighted aptamers were selected for further analysis. 
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was too harsh, resulting in loss of potential aptamers, we went back to the round 11 li-
brary and carried out 9 more rounds using only positive selections. After the 9 rounds 
were completed, we again cloned and sequenced the library. Upon alignment, we found 
8 more unique families. We tested one sequence from each family for target dependent 
displacement, but once again found that we had not successfully selected a functional 
aptamer biosensor. This led us to attempt a second cycle of capture-SELEX using a new 
library.   
 
Structure-switching SELEX Trial 2
 Morse and coworkers preformed a displacement style SELEX similar to capture-
SELEX but with a different capture strand binding position.22 In their version, the capture 
strand was complementary to the 5’ region of the library. Using this library, we performed 
selections similar to those in the previous trial with the exclusion of the negative selec-
tion steps. We chose to greatly decrease the stringency of the selections to maximize 
our chances of successfully selecting a biosensor. 
 M-270 streptavidin beads were conjugated with 3’ biotin labeled capture strands. 
For the first round, 2.5 nmols of library was annealed to the capture strand labeled 
beads. This was accomplished through a snap cool of the library followed by a 3-hour 
incubation at room temperature with nutation. The beads were thoroughly washed 10 
times for 5 minutes each wash. Each wash was collected and the amount of library 
quantified to determine the amount of library that was successfully annealed to the 
beads. The beads were then incubated with 1 mM (S)-CMA for 30 minutes followed by 
collection of the supernatant. The (S)-CMA elution was then PCR amplified and strand 
separated by denaturing PAGE. The band corresponding to the library was excised, ex-
tracted, and incubated with fresh capture strand labeled magnetic beads to begin the 
next round. This process was carried out until slight enrichment of the library was seen 
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at round 17 (Figure 3.15). After 17 rounds, the library was tested with a bead elution ap-
proach.  
 Fresh capture strand labeled beads were incubated with the round 17 library and 
separated into 3 tubes. The 3 tubes were each incubated with buffer, (R)-CMA, or (S)-
CMA at 1 mM. The percent elution for each was calculated using a fluorescence plate 
reader and found to be the same within error for all 3 samples. This led us to believe that 
this cycle had failed to produce any aptamers that would function as structure-switching 
biosensors. We hypothesized that the preselection washes were too harsh and thereby 
removed too much of the library. This led us to attempt a third cycle of selections using 




Figure 3.15. Enrichment of library for trial 2 of structure-switching SELEX. Control and 





















Structure-switching SELEX Trial 3
 Trial 3 was carried out identically to trial 2 using the Morse library, except that the 
preselection washes were decreased in number from 10 to 5 washes. A total of 10 
rounds were performed in this trail, at which time no clear enrichment of the library was 
observed (Figure 3.16). Although little to no enrichment was seen at this point, we de-
cided to test the library using the bead elution approach. Fresh capture strand labeled 
beads were incubated with the round 10 library and separated into 3 tubes. The 3 tubes 
were each incubated with either buffer, (R)-CMA or (S)-CMA at 1 mM. It was found that 
the percent displacement for the samples were again all within error. This led us to be-
lieve that this SELEX trial was going to suffer the same fate as the previous trial. We 
abandoned this trial and chose to test the trial 1 library again with less stringent pre-





Figure 3.16. Enrichment of library for trial 3 of structure-switching SELEX. Control and 






















Structure-switching SELEX Trial 4
 Trial 4 was performed in the same way as trial 3 except we used the Strehlitz li-
brary and chose to do 2 positive elutions with (S)-CMA to determine if the less stringent 
preselection washes or the additional positive selection would affect our outcome. We 
hypothesized that the second positive elution step would allow for more potential ap-
tamers to be collected. We performed 10 rounds and saw a small enrichment of the li-
brary (Figure 3.17). We were encouraged by the enrichment at this point so we tested 
the library using the bead elution approach. Fresh capture strand labeled beads were 
incubated with the round 10 library and separated into 3 tubes. The 3 tubes were each 
incubated with either buffer, (R)-CMA or (S)-CMA at 1 mM. We once again found that 




Figure 3.17. Enrichment of library for trial 4 of structure-switching SELEX. Control and 























Structure-switching SELEX Trial 5 
 For trial 5, we chose to test the Morse library using the same protocol employed 
in trial 4, except the 5 preselection washes were carried out for 30 seconds instead of 5 
minutes. We also chose to select for a new target. We changed the target to (S)-2-
chloromandelic methyl ester ((S)-CME). There were two important reasons for the switch 
in our target. First, the cytochrome P450 enzymes from the Arnold lab accept phenyla-
cetic esters as substrates, but not phenylacetic acids.  Thus, having a sensor for the es-
ter would put us in better position to screen P450 variants. Second, our colleagues in the 
Burrows group at the University of Utah had shared with us unpublished work in which 
they had great difficulty selecting for targets that contained a carboxylic acid group. We 
began selections using the new target (S)-CME, and after 9 rounds of selection, we had 
seen no significant enrichment, but chose to test the library to see if any sequences that 
bound to (S)-CME had emerged (Figure 3.18). We tested the library using the bead elu-




Figure 3.18. Enrichment of library for trial 5 of structure-switching SELEX. Control and 





















Structure-switching SELEX Trial 6
Trial 6 was carried out in the same way as trial 5 except we only performed a 
single preselection wash for 15 minutes. We hypothesized that in the previous trials, the 
extensive washing of the library-bound beads was thinning out the library too much and 
only leaving us with limited sequences that bound tightly to the capture strand. We per-
formed 13 rounds and were encouraged to see enrichment (Figure 3.19). We then used 
the bead elution method to test the library but once again saw that the library did not 
displace in the presence of the target. Following this trial, we felt that these methods 
were not amenable to the selection of structure-switching aptamers for very small mole-
cules and therefore chose to look into a more powerful method for the selection of small-
molecule-binding structure-switching aptamers. The major limiting factor to bead-based 
SELEX methods is the high background from nonspecific elution in each round, leading 
to the need to perform >10 rounds of selections to successfully obtain an aptamer. Our 
search for more powerful methods hinged on finding a separation method able to in-
crease the partitioning of bound and unbound sequences. 
 
 























Capillary electrophoresis structure-switching aptamer SELEX
 Capillary electrophoresis (CE) has been successfully used to select for tradition-
al aptamers in as little as one round.23 The power of CE lies in its incredibly efficient par-
titioning ability. However, the major limitation of CE is that the target must be of high 
enough molecular weight to cause a shift in mobility when bound to a library member. 
This limitation severely hinders the applicability of CE SELEX for small-molecule ap-
tamer selections.  We discovered that many groups had successfully circumvented this 
problem and used CE to separate low molecular weight targets by appending a drag tag 
(high molecular weight molecule) to one of the molecules.  Therefore, we hypothesized 
that by designing a CE structure-switching SELEX method with a drag tag on the cap-
ture strand, we could select structure-switching aptamers for smaller targets. 
We first attempted selections using a displacement strand modified with a PEG 
spacer and a T20 (PT20) as a drag tag (Figure 3.20). We began optimization of the sepa-
ration but found that the standard bare fused silica (BFS) capillary would not work with 
our system. In capillary electrophoresis, there are three dominating forces that lead to 
migration within the column (Figure 3.21). First, the electromotive force is dictated by the 
charge density of the molecules. In our case, we were running in reverse phase, allow-
ing for negatively charged molecules to traverse the column toward the positive terminal. 
The second force is drag, which is related to the size and structure of the molecules. Fi-
nally, electroosmotic flow (EOF) is the flow of the bulk solvent towards the negative ter-
minal. EOF is caused by the negatively charged silanol groups on the walls of the BFS 
capillaries. We found that the EOF increased both migration time and broadened peak 
width, leading to very poor separation of the molecules. Elimination of the EOF is possi-
ble through the use of a high pH (>9.4) buffer, or through modification of the capillary 




Figure 3.20. Library and capture strand PT20 design for CE SELEX. Red/purple = PT20; 





Figure 3.21. Comparison of the effects a BFS capillary (top) and a CEP capillary (bot-
tom) have on the migration of a structure-switching SELEX library. 
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our system. We chose to use a CEP capillary that is functionalized with a layer of PEG 
on the walls, which eliminates the EOF. 
Next, we optimized the ionic strength of the buffers used in the system. High ion-
ic strength or the presence of divalent ions leads to limited separation as well as joule 
heating within the capillary. This becomes important for structure-switching SELEX, as 
the displacement strand must anneal to the library strongly enough to prevent nonspecif-
ic dissociation, while being labile enough to displace upon target binding. For instance, 
we were able to achieve baseline separation of the aptamer library from PT20 by de-
creasing the ionic strength to 10 μM monovalent ions, but we found that over 50% of the 
complex nonspecifically disassociated in solutions with such a low ionic strength. 
These results led us to explore displacement strands modified with bulkier drag 
tags to increase separation, allowing the use of higher ionic strengths. We first explored 
the use of proteins as drag tags. The displacement strand was synthesized having a 3’ 
biotin and attached to streptavidin, avidin, or neutravidin drag tag constructs. These 
were each tested in various ionic strength solutions to find the maximum concentration 
of monovalent ions that would still provide sufficient separation. The separation of the 
complexes was not as good as we had expected, and we hypothesized that this was due 
to the tetrameric nature of these protein tags. For example, each streptavidin has four 
biotin binding sites, thereby allowing for attachment of up to 4 capture strands and library 
members. This diversity led to very broad peaks and still required very low ionic 
strengths to provide sufficient separation. We found again that to achieve baseline sepa-
ration, the ionic strength had to be reduced to <10 μM monovalent ions to achieve suffi-
cient separation, resulting in an unacceptable level of nonspecific dissociation (Figure 
3.22). 
We next explored monovalent streptavidin to decrease the peak width, thereby 




Figure 3.22. Electropherogram showing separation of free library and bound library. 
Baseline separation was achieved at low ionic strength but this led to high nonspecific 
dissociation of complex. Streptavidin is shown as binding only one biotin for simplicity. 
 
acquired through ADDGENE.  However, we found that this process was very laborious 
and after expression and purification, we obtained very little protein. The difficulty of ob-
taining a sufficient amount of protein for selection led us to abandon this method as we 
aim to develop a simple, widely applicable selection strategy. Therefore, the time and 
effort required to produce the monovalent streptavidin was determined to be incongruent 
with our goals.  
Latex microspheres, on the other hand, are cheap, available in many sizes, and 
have a wide variety of attachment chemistries. We choose to use 60 nm latex spheres 
having aldehyde functional groups. This size allowed us to maximize surface area while 
increasing the number of spheres that could be injected into the capillary for each run. 
The remainder of the surface was covered in sulfate groups, resulting in a high negative 
charge on the spheres, allowing for a greater separation. Displacement strands modified 
with a 3’ C6-NH2 were synthesized and reductive amination was used to attach them to 
the microspheres. The functionalized microspheres were incubated with fluorescein la-
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beled library and injected onto the capillary. Currently, we are exploring the effect of 
loading density on the separation of bound and unbound library. We anticipate that hav-
ing the ability to control loading density of the displacement strands onto the latex micro-
spheres will provide more precise control of separation and allow for higher ionic 
strengths to be used. 
Conclusion
Much of our research has focused on development of an efficient selection pro-
cedure for reliably generating structure-switching DNA biosensors. This has proven to be 
the greatest hurdle for the integration of aptamers into our analytical applications. Our 
lab has focused on small-molecule selections, as these represent the most difficult tar-
gets for biosensor design. As such, we hypothesized that designing a robust selection 
method for small molecules would be more generalizable than methods for larger tar-
gets. The purpose of this chapter was to define the current limitations for selecting small-
molecule aptamers and to provide alternative selection strategies. Clear evidence of the 
extent of these challenges in biosensor selection can be seen by the near exclusive use 
of the same handful of aptamer biosensors in the literature.  
A practical application for these small-molecule biosensors is detailed in Chapter 
2.  Future work for (S)-CMA aptamers created in the Heemstra lab will be focused on the 
screening of P450 libraries to generate an enzyme that will produce 2-CMA with a com-
mercially viable enantioselectivity. This will be accomplished by performing site-
saturation mutagenesis on a variant of BM-3 reported by Arnold and coworkers.9 The 9-
10A-F87A mutant has been shown to hydroxylate substituted mandelic methyl esters. 
This mutant has high substrate specificity but only moderate enantioselectivity. The mu-
tants would be screened for the stereochemistry of the alpha hydroxylation performed on 
2-chlorophenylacetic methyl ester, producing 2-chloromandelic methyl ester, and the bi-
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osensors being created would be used to measure the enantioselectivity of enzyme mu-
tants. The use of aptamer-based screening methods will dramatically increase the num-
ber of mutants that can be screened, leading to enhanced efficiency and selectivity.  
Materials and Methods
General methods
Unless otherwise noted, all starting materials were obtained from commercial 
suppliers and used without further purification. All DNA was purchased from the Universi-
ty of Utah DNA/Peptide Synthesis Core Facility. All absorbance and fluorescence values 
were recorded using a Biotek Synergy Mx microplate reader. All DNA sequences used in 
Chapter 3 can be found in Table 3.1. All buffers used in Chapter 3 can be found in Table 
3.2. 
Modifiers used for DNA synthesis
Fluorescein was installed using phosphoramidites obtained from Glen Research. 
Black Hole quencher 1, biotin, and C6-NH2 modifiers were installed using CPG cartridges 
from Glen Research.  
PCR conditions
PCR1-87 [5 min 95 ⁰C,20x (1 min 94 ⁰C, 1 min 47 ⁰C, 1 min 72 ⁰C) 10 min 72 ⁰C] 
Primers (jh0614-2 and jh0614-5) 
PCRSSS  [3 min 95 °C,15x (1 min 95 °C, 1 min 51 °C, 1 min 72 °C) 10 min 72 °C] 
Primers (AP60 and Ter-AP20)
PCRSSS2  [3 min 95 °C,15x (30 sec 95 °C, 30 sec 60 °C, 45 sec 72 °C) 2 min 72 °C] 
Primers (FP-II-30 and RP-II-30) 
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Table 3.1. Nucleic acid sequences and modifications used throughout Chapter 3. Where 

























Table 3.2. All buffers used throughout Chapter 3
Binding buffer 
 [BB1-9] 
10 mM Tris-HCl, 100 mM NaCl, 5 mM KCl, 2 mM MgCl2, 1 
mM CaCl2, pH 7.5
Wash conjugation buffer 
[WCB1-9] 
0.1 M sodium phosphate, 0.15 M NaCl, pH 7.4
Elution buffer 
 [EB1-74] 
40 mM Tris-HCl, 10 mM EDTA, 3.5 M Urea, 0.02% tween 20
Reduction buffer 
 [RB1-9] 
5 M NaCNBH3 in 1 M NaOH
Blocking agent  
[BA1-9] 
0.1 M ethanolamine pH 7.4
Bind and Wash  
[B&W] 
10 mM Tris-HCl, 1 mM EDTA, 2 M NaCl, pH 7.5
Crush and soak  
[C&S] 
2 mM EDTA, 300 mM NaOAc
CE buffer 
[RB-69-10] 




100 mM MES, 10 mM NaCl, pH 6 
Microsphere reduction 
buffer [MSRB] 







FluMag magnetic bead preparation
 M-270 amine functionalized magnetic beads were obtained from Invitrogen for all 
FluMag SELEX experiments. Bead conjugation was performed as follows; solutions of 
aldehyde modified (S)-CMA were made at 10 mg/mL in WCB1-9. 1 mL of M-270 beads 
were placed on a magnet for 4 minutes and the supernatant was removed. Beads were 
then resuspended in 1 mL of WCB1-9. This process was repeated 3 times followed by 
addition of 1 mL of the aldehyde modified (S)-CMA solution. 10 μL of RB1-9 was added 
and the solution was left to incubate for 2 hours on a nutating mixer at 25 °C. Following 
incubation, the beads were placed on a magnet and the supernatant was removed. 1 mL 
of BA1-9 was added and the solution was incubated for an additional 15 minutes on a 
nutating mixer at 25 °C. The beads were then washed 3 times with WCB1-9 followed by 
3 washes with BB1-9. Beads were now ready for selection rounds and will be referred to 
as (FB-FM). 
Structure-switching magnetic bead preparation
 M-270 streptavidin functionalized magnetic beads were obtained from Invitrogen. 
1 mL of beads were washed 3 times with B&W. On the final wash, B&W was added to 
produce a concentration 109 beads per mL. Next, 600 pmols of TMC-3-i-odn2sp capture 
strand was added per 108 beads. The resulting solution was incubated at room tempera-
ture for 1 hour on a nutating mixer. Beads were then washed 3 times with B&W followed 
by 3 times with BB1-9. Beads were now ready for selection rounds and will be referred 
to as (PB-SS).  
 
Microsphere bead preparation
 Aldehyde/sulfate 0.06 μm superactive latex beads were obtained from Life Tech-
nologies. Approximately 1012 latex beads were dialyzed 2 times for >3 hours with MSCB 
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using 20 kDa dialysis tubing. 50 nmols of TMC-II-72-1 was added to the equilibrated mi-
crospheres in 100 μL of MSCB. 5 μL of MSRB was added and the mixture was incubat-
ed at 37 ⁰C for 24 hours. The reaction was stopped through the addition of 0.1 mM etha-
nolamine and finally dialyzed 3 times for >3 hours with RB-69-10 using 20 kDa dialysis 
tubing. The microspheres were now ready for use. 
FluMag SELEX general procedure
 For the first round of selection, 6 nmols of jh0614-1 was snap cooled (heating to 
90 ⁰C for 8 minutes, followed by 4 ⁰C  for 10 minutes and finally equilibration at 25 ⁰C for 
5 minutes) and then incubated for 2 hours on a nutating mixer with 50 μL of FB-FM  in a 
total volume of 500 μL of BB1-9. Subsequent rounds used 200 pmols of the library from 
the previous round with a fresh 50 μL of FB-FM. The solution was then placed on a 
magnet for 4 minutes and the supernatant was removed. The beads were washed 5 
times by adding 200 μL of BB1-9, briefly vortexing, magnetically separating, and remov-
ing the supernatant. If negative selections were performed, they were done at this stage 
by incubating the beads with the negative target for 30 minutes on a nutating mixer, 
magnetically separating, and removing of the supernatant. Next, 200 μL of BB1-9 con-
taining the target of interest was added, briefly vortexed, and incubated at 25 °C for 30 
minutes. Following the incubation, the solution was magnetically separated and the su-
pernatant collected. The beads were then heat eluted to remove any library members 
that were tightly bound to the bead-bound targets. This was accomplished by the addi-
tion of 200 μL of EB1-74 and heating to 80 °C for 8 minutes. Before the solution was al-
lowed to cool, it was magnetically separated, and the supernatant was removed. 
The elutions were all quantified at this point using a 96 well plate and a fluores-
cence plate reader. The positive and the heat elutions were combined and PCR ampli-
fied in16 parallel 100 μL reactions using PCR1-87. The 16 reactions were pooled and 
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purified using a Qiagen minielute PCR clean up kit. The purified dsDNA was then sepa-
rated using a 10% denaturing PAGE gel for ~60 minutes at 120 volts. Gels were then 
imaged on a UV transilluminator and the fluorescein bands were excised. The excised 
bands were crushed and placed in 500 μL of C&S and placed at -80 ⁰C for 1 hour and 
then immediately placed on a heat block at 90 ⁰C for 150 minutes. The gel fragments 
were then removed using a 0.2 μM spin filter. Purified library was concentrated using 10 
kDa spin filters and used for the next round of selection.   
Structure-switching SELEX general procedure
 2.5 nmols of TMC-II-2-N40 was incubated with 109 of PB-SS for the first round. 
Subsequent rounds used an average of 200 pmol of library from the preceding round 
with 108 of fresh PB-SS. Library was suspended in BB1-9 and snap cooled (heating to 
90 ⁰C for 8 minutes, followed by 4 ⁰C for 10 minutes and finally equilibration at 25 ⁰C for 
5 minutes) and incubated with PB-SS for 18 hours at 25 ⁰C on a nutating mixer. Next, 
beads were stripped of nonbinding library members through a series of washing steps. 
This was accomplished by placing the tubes on a magnet for 4 minutes, then removing 
the supernatant and adding an equal volume of BB1-9. Time and quantity of washes var-
ied between cycles and the specifics can be found within cycle descriptions. If negative 
selections were performed, they would be done at this point followed by washes. Finally, 
positive elutions were performed using target molecule in BB1-9. Tubes were placed on 
the magnet for 4 minutes and binding sequences were collected in the supernatant. 
Quantification of eluted library was carried out in a 96 well plate with a fluorescence 
plate reader.  
 Positive elutions were then PCR amplified in 16 parallel 100 μL reactions using 
PCRSSS for cycles 1, 4 and PCRSSS2 for cycles 2, 3, 5, and 6. The 16 reactions were 
pooled and purified using a Qiagen minielute PCR clean up kit. The purified dsDNA was 
81
  
then separated using a 10% denaturing PAGE gel for ~60 minutes at 120 volts. Gels 
were then imaged on a UV transilluminator and the fluorescein bands were excised. The 
excised bands were crushed and placed in 500 μL of C&S and placed at -80 °C for 1 
hour and immediately placed on a heat block at 90 °C for 150 minutes. The gel frag-
ments were removed using a 0.2 μM spin filter, and purified library concentrated using a 
10 kDa spin filter, and used for the next round of selection. 
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CONVENIENT AND SCALABLE SYNTHESIS OF FMOC-PROTECTED 
PEPTIDE NUCLEIC ACID BACKBONE*
Introduction 
Peptide nucleic acid (PNA) has recently emerged as a promising alternative to 
the native nucleic acids DNA and RNA (Figure 4.1) for a wide variety of applications in-
cluding antisense therapy and gene diagnostics.1-3  The key advantages of PNA over 
DNA and RNA are its resistance to degradation by cellular nucleases and its relatively 
higher binding affinity and mismatch selectivity in duplex formation.4-5  PNA can be gen-
erated by Fmoc- or Boc-solid phase peptide synthesis,6 and Fmoc-protected monomers 
bearing each of the four canonical nucleobases are commercially available.  Recently, 
the incorporation of modified nucleobases into PNA has been shown to enable synthesis 
of nucleic acids having unique physicochemical properties.7 However, PNA monomers 
bearing modified nucleobases are not commercially available, and must instead be syn-
thesized in the laboratory.  Suitable reactions have been reported for preparation of 
modified nucleobases and coupling of these nucleobase acetic acids to the PNA back-
bone (Figure 4.2).7-8  However, to our knowledge, a scalable and cost-effective synthesis 
for the protected N-[2-(Fmoc)aminoethyl]glycine benzyl ester (Fmoc-AEG-OBn) back- 
_______________________ 
* Adapted under the terms of the Creative Commons Attribution License from Feagin, T. A.;
Shah, N. I.; Heemstra, J. M. Convenient and Scalable Synthesis of Fmoc-Protected Peptide Nu-
cleic Acid Backbone. J. Nucleic Acids. 2012, 2012, 354549.










bone 1 has yet to be reported.9 Here we describe a synthesis of 1 that proceeds in four 
steps with an overall yield of 32%, utilizes inexpensive reagents, and can be scaled to 
produce large quantities of final product in a single batch with only minimal purification.  
 
Results and Discussion
An extensive literature search reveals only one published route to 1, as shown in 
Figure 4.3a.  This route, reported by Hudson and coworkers, proceeds in three steps 
with an overall yield of 81%, but requires the use of costly N-(2-aminoethyl)glycine as 
the starting material.8  Furthermore, in our hands, this synthetic route has proven difficult 
to reproduce.  Alternatively, Porcheddu and coworkers have described a synthesis of 
Fmoc-AEG-OMe 2 that proceeds in three steps with an overall yield of 66% (Figure 
4.3b), but requires three equivalents of IBX to accomplish the oxidation step.9  Thomson 
and coworkers have described a synthesis of Fmoc-AEG-Ot-Bu.HCl 3.HCl that proceeds 
in two steps with 46% overall yield from inexpensive starting materials (Figure 4.3c), but 
does not produce analytically pure material.10-13  Furthermore, the exocyclic amines of 
the PNA nucleobases are typically protected with acid-labile Boc or Bhoc protecting 
groups.  Deprotection of the tert-butyl ester requires strongly acidic conditions, making 3 
unsuitable for use with Boc- or Bhoc-protected nucleobases.  
Inspired by the ease and cost-effectiveness of the Thomson route, we first envi-
sioned synthesis of 1 by alkylation of ethylenediamine with benzyl bromoacetate, fol-
lowed by reaction with Fmoc N-hydroxysuccinimide ester (Fmoc-OSu).  Unfortunately, 
after alkylation and aqueous workup, only benzyl alcohol was recovered.  We hypothe-
size that alkylation product 4 rapidly cyclizes to give benzyl alcohol and water soluble 
cyclic piperazinone 5 (Figure 4.4a), and that this undesired cyclization can only be sup-
pressed by the use of a bulky ester such as a tert-butyl ester.  In fact, this cyclization has 
been demonstrated previously using the analogous methyl ester.14 We next considered  
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 reversing the order of the two reactions such that ethylenediamine would first be mono-
protected with Fmoc-OSu, then alkylated with benzyl bromoacetate to give 1.  However, 
Fmoc-ethylenediamine cannot be directly prepared by the reaction of ethylenediamine 
with Fmoc-Cl or Fmoc-OSu.  Rather, a three-step process is required in which ethylene-
diamine is mono-Boc protected (6), then Fmoc protected (7), and finally the Boc group 
removed under acidic conditions to give 8 as the TFA salt.15 Unfortunately, our attempts 
to alkylate 8.TFA with benzyl bromoacetate failed to yield the desired product 1, likely 
due to the instability of the free base of 8 (Figure 4.4b). 
Fortunately, we were able to obtain Boc-ethylenediamine 6 in 80% yield from 
ethylenediamine and Boc anhydride using a modified version of a reported procedure, 
and this was successfully alkylated with benzyl bromoacetate to give 9 in 72% yield.16 
We then deprotected the Boc group using trifluoroacetic acid (TFA) to give a quantitative 
yield of free amine, which was importantly found to be stable to cyclization when isolated 
as the TFA salt.  In the final step, we combined the amine TFA salt with Fmoc-OSu prior 
to adding base, so that protection of the primary amine could compete with cyclization to 
give the desired product 1 in 55% yield.  Starting with 50g of Boc anhydride, we were 
able to generate 31g of analytically pure 1 in a single batch using inexpensive reagents 
(Figure 4.4c).17 
A key to the scalability of our synthetic route is the relatively facile purification of 
the synthetic intermediates and final product.  The Boc protection step to give 6 requires 
only aqueous workup, and the deprotection step requires simple concentration and re-
moval of TFA via formation of an azeotrope with toluene.  The alkylation to produce 9 
and the Fmoc protection to give 1 require flash column chromatography, but a large dif-
ference in Rf between the products and impurities makes purification possible using only 
a silica plug. 
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Figure 4.4. Synthetic route to Fmoc-AEG-OBn 1.
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Fmoc-protected PNA backbone 1 is a key intermediate in the synthesis of Fmoc-
protected PNA monomers having modified nucleobases.  However, to date, a scalable 
and cost-effective synthetic route to this molecule has yet to be reported in the literature. 
An efficient synthesis of the Boc-protected backbone has been reported, but our at-
tempts to utilize this synthetic route with Fmoc in place of Boc failed to give product, like-
ly due to the instability of synthetic intermediate 8.  Rather, synthesis of 1 can be initiat-
ed using a Boc protecting group, followed by a protecting group swap to provide the 
Fmoc-protected product.  The first two steps of our synthetic route mirror those of the 
published synthesis for the Boc-protected monomer.18 However, replacement of the Boc 
group with Fmoc poses a significant challenge, as this step proceeds through unstable 
intermediate 4.  We were able to perform this transformation by generating the free base 
of 4 at reduced temperature and in the presence of Fmoc-OSu, enabling Fmoc-
protection to effectively compete with cyclization, providing 1 in moderate yield. 
Conclusion
In summary, we describe here a novel route to the PNA backbone Fmoc-AEG-
OBn 1.  Using this route, we have rapidly synthesized 31g of 1 using inexpensive start-
ing materials and only minimal purification.  The overall yield for our synthetic route is 
modest at 32%; however, the low cost of starting materials and ease of purification ena-
ble this synthesis to be tractable on a large scale.  Having a convenient route to access 
1 is anticipated to ease the synthesis of new Fmoc-protected PNA monomers, presuma-




Unless otherwise noted, all starting materials were obtained from commercial 
suppliers and were used without further purification. Flash column chromatography was 
carried out using silica gel 60 (230-400 mesh).  1H and 13C NMR chemical shifts are ex-
pressed in parts per million (δ) using residual solvent protons as internal standard (G 
7.26 ppm (1H) and 77.16 ppm (13C) for CHCl3). Coupling constants, J, are reported in 
Hertz (Hz), and splitting patterns are designated as s (singlet), d (doublet), t (triplet), q 
(quartet), m (multiplet), br (broad), and app (apparent). Mass spectra were obtained 
through the Mass Spectrometry Facility, University of Utah. 
tert-Butyl (2-aminoethyl)carbamate (6)
A 2 L round bottom flask was charged with ethylenediamine (306.5 mL, 4.58 mol) 
and tetrahydrofuran (600 mL).  Boc anhydride (50.0 g, 229 mmol) was dissolved in 400 
mL tetrahydrofuran and added to the solution of ethylenediamine via addition funnel over 
45 minutes with vigorous stirring.  After 18 hours, the reaction was quenched by addition 
of 500 mL H2O.  The aqueous phase was saturated with solid K2CO3, then the phases 
separated and the organic phase dried over Na2SO4, filtered, and concentrated to give a 
pale yellow oil.  The oil was dissolved in 700 mL toluene and concentrated to azeotrope 
remaining ethylenediamine, yielding 29.24 g of pale yellow oil (80%).  1H NMR (300 
MHz, CDCl3) G 4.90 (br s, 1H), 3.16 (q, J = 5.8 Hz, 2H), 2.78 (t, J = 5.9 Hz, 2H), 1.43 (s, 
9H), 1.09 (br s, 2H).  13C NMR (75 MHz, CDCl3) G 156.3, 79.1, 43.3, 41.8, 28.4.  HRMS 
(ESI) m/z 161.1295 (calcd [M+H]+ = 161.1290). 
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Benzyl 2-((2-((tert-butoxycarbonyl)amino)ethyl)amino)acetate (9) 
A 2 L round bottom flask was charged with 6 (29.24 g, 183 mmol), triethylamine 
(25.5 mL, 183 mmol), and acetonitrile (450 mL).  The reaction mixture was stirred and 
ethyl bromoacetate (28.9 mL, 182 mmol) added via syringe over 2 minutes.  After 100 
minutes, the reaction mixture was diluted with 500 mL EtOAc and washed with 500 mL 
2M K2CO3 (aq.), then 500 mL brine.  The organic phase was dried over Na2SO4, filtered, 
and concentrated to a pale yellow oil, which was purified by flash column chromatog-
raphy, (70 mm diameter column, 285 g silica gel, 1:1 hexanes:EtOAc, 99:1 EtOAc:Et3N) 
to give 40.56 g of pale yellow oil (72%).   1H NMR (300 MHz, CDCl3)G  7.38-7.33 (m, 
5H), 5.17 (s, 2H), 4.99 (br s, 1H), 3.45 (s, 2H), 3.20 (q, J = 5.7 Hz, 2H), 2.74 (t, J = 5.8 
Hz, 2H), 1.59 (br s, 1H), 1.44 (s, 9H).  13C NMR (75 MHz, CDCl3) G 172.3, 156.1, 135.5, 
128.6, 128.4, 128.3, 79.0, 66.5, 50.4, 48.7, 40.1, 28.4.  HRMS (ESI) m/z 331.1640 (calcd 
[M+Na]+ = 331.1634). 
Benzyl 2-((2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)ethyl)amino)acetate
(Fmoc-AEG-OBn 1)
To a 2 L round bottom flask was added 9 (40.46 g, 131 mmol) and dichloro-
methane (200 mL).  The reaction mixture was stirred in an ice bath and 200 mL trifluoro-
acetic acid added.  The ice bath was removed and the reaction mixture stirred for 20 
minutes, then concentrated to a yellow oil.  The oil was dissolved in 400 mL toluene and 
concentrated to azeotrope remaining trifluoroacetic acid.  The resulting yellow oil was 
dissolved in 700 mL dichloromethane and stirred under N2 in an ice bath.  Fmoc-OSu 
(44.26 g, 131 mmol) was added all at once, then triethylamine (54.8 mL, 393 mmol) 
added dropwise via addition funnel over 5 minutes.  The ice bath was removed and the 
reaction mixture stirred for 2 hours, then washed with 500 mL 1M K2CO3 (aq.), dried 
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over Na2SO4, filtered, and concentrated to a yellow oil.  The oil was purified by flash col-
umn chromatography, (70 mm diameter column, 250 g silica gel, 1:1 hexanes:EtOAc, 
98:2 EtOAc:MeOH) to give 31.04 g of pale yellow oil that crystallized into a white solid 
upon standing (55%).   1H NMR (300 MHz, CDCl3) G7.76 (d, J = 7.4 Hz, 2H), 7.61 (d, J = 
7.3 Hz, 2H), 7.42-7.28 (m, 9H), 5.29 (br s, 1H), 5.18 (s, 2H), 4.40 (d, J = 7.0 Hz, 2H), 
4.22 (t, J = 6.8 Hz, 1H), 3.47 (s, 2H), 3.29 (q, J = 5.4 Hz, 2H), 2.78 (t, J = 5.6 Hz, 2H), 
1.58 (br s, 1H).  13C NMR (75 MHz, CDCl3) G 172.3, 156.6, 144.0, 141.3, 135.5, 128.6, 
128.5, 128.4, 127.6, 127.0, 125.1, 120.0, 66.6, 66.4, 50.4, 48.6, 47.3, 40.6.  HRMS (ESI) 
m/z 431.1972 (calcd [M+H]+ = 431.1971). 
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CHAPTER 5
CONCLUSION AND FUTURE DIRECTIONS
Enzyme Evolution
The field of enzyme screening and evolution has been advanced recently by a 
number of research labs who have shown that enzymes can be adapted to perform con-
versions similar to many exotic chiral catalysts at a fraction of the cost.1-8 Through their 
work, enzyme mutation has been made trivial, allowing massive libraries of mutant en-
zymes to be created within a matter of days. As such, the limitation of enzyme evolution 
has become screening these vast libraries. Reetz has developed powerful HPLC meth-
ods for screening the libraries for enantioselectivity. However, these techniques are still 
only capable of screening a few thousand samples per day, severely limiting the selec-
tion process. Other groups have also worked to increase the throughput of enantiopurity 
screening.9-17 Anslyn and coworkers have shown that the use of supramolecular sensors 
can increase the efficiency of screening, demonstrating the ability to analyze greater 
than 4000 samples per day.18 The limitations of this system originate from the need to 
independently measure concentration prior to gaining knowledge of enantiopurity. There-
fore, while this method represents a step forward in developing high-throughput meth-
ods, it does not approach the necessary efficiency for screening the massive libraries 
generated in enzyme evolution. 
The Heemstra lab has shown a strong dedication to advancing aptamer technol-
ogies, and has pioneered a method for using aptamers to measure concentrations of 
enantiomers in solution. We hypothesized that by using an enantioselective aptamer and 
its Speigelmer, orthogonal biosensors could be created to provide accurate concentra-
tion and enantiopurity information for a mixture of enantiomers. We demonstrated this 
concept using a previously reported tyrosinamide aptamer19 as described in Chapter 2, 
and showed that our orthogonal biosensors could accurately discriminate complex mix-
tures of L- and D-Tym. Our system rivals HPLC in accuracy, showing < 1.7% error for 
complex reaction mixture, and has the ability to work in near real-time. Additionally, this 
method demonstrates exceptionally high-throughput, allowing for mixtures to be 
screened in a few minutes as opposed to the > 17 hours that would be required using 
HPLC.  
One hurdle to widespread adoption of this technology for enzyme evolution is the 
ability to obtain aptamers that are highly enantioselective. While it is often difficult to se-
lect aptamers with extremely high enantioselectivities (~10,000:1), we derived a mathe-
matical equation that allows for aptamers with even modest enantioselectivity (i.e. ~10:1 
for our model system) to be used for determining enantiopurity. This greatly increases 
the practicality of our method, as it is considerably easier to select for moderate enanti-
oselectivity, even without the use of negative selections, as shown by our work in Chap-
ter 3. The one limitation to the equation arises from the loss of information regarding 
concentration, since the equation can only provide a ratio of the two enantiomers. This 
limitation is acceptable because in screening of enantioselective enzyme mutants, a ra-
tio of enantiomers is sufficient to determine the best mutant. Therefore, we envision that 
our approach will be amenable to screening the products of enzyme-mediated reactions.  
Nucleic acid aptamers show tremendous potential with wide applicability in many 
fields due to their unrivaled specificity, low cost, and ability to be generated by in vitro 
selection.  Many powerful new technologies are being improved through the use of these 
versatile affinity reagents. However, we recognize the greatest limitation of integrating 
98
aptamers into applications such as our enantiopurity analysis method is the difficulties 
associated with obtaining sequences having a privileged architecture that can be easily 
converted to a biosensor. This obstacle is evident in researchers’ continued use of the 
same handful of aptamers, which have already been established in their compatibility 
with a variety of different detection platforms. Our focus has shifted accordingly to ad-
dress this growing problem through the design of new aptamer selection techniques. 
 
Aptamer Biosensor Selection
Traditional bead-based selections, like FluMag, work very well for selecting affini-
ty reagents, as demonstrated by our selection of the highly enantioselective (S)-CMA 
aptamer, BH6t. As shown in Chapter 3, this aptamer performs well as an affinity reagent, 
demonstrating excellent specificity and enantioselectivity (>100:1). However, attempts to 
convert BH6t into a structure-switching biosensor were unsuccessful. This is likely due to 
the fact that this biosensor format typically requires a large conformational change upon 
target binding, and small molecules like 2-CMA often produce only small perturbations in 
the structure of the aptamer. Therefore, the displacement event must be part of the se-
lection process to ensure that the small change will displace the strand efficiently. This is 
a major problem within the field and is being vigorously pursued by many groups, includ-
ing our own. We seek to address this challenge through development of methods for the 
direct selection of aptamer biosensors. This dissertation discusses our methods and fu-
ture goals to advance new technologies in the selection and applications of aptamer bio-
sensors for small molecules. 
 Towards these goals, we have explored several methods, both established and 
novel, for directly selecting the privileged displacement strand architecture required for 
structure-switching biosensors. We have found that while many traditional methods are 
successful in generating aptamers that can easily be converted to biosensors for larger 
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targets, such as proteins, they are far from generalizable and often fail when challenged 
with small-molecule targets. Incorporating the requirement of a large conformational 
change within the selection process for small-molecule-binding has shown promise for 
many groups. We tested two of the leading structure-switching SELEX methods to eval-
uate their ability to successfully select for a 2-CMA structure-switching biosensor. Unfor-
tunately, our six different structure-switching SELEX trials were unsuccessful in produc-
ing a high affinity biosensor for 2-CMA. We hypothesize that this may be due to the well-
known issues of structure-switching methods which rely on the use of a solid support, 
typically magnetic beads. We have found that magnetic bead-based selections generate 
high levels of nonspecific background and reason that this leads to poor enrichment, 
lower affinity aptamers, and/or failed selections. Therefore, our current efforts aim to de-
sign a generalizable structure-switching SELEX approach that does not require a solid 
support and will be compatible with targets of any size.  We hypothesize that capillary 
electrophoresis (CE) will provide the level of partitioning and lack of matrix effects nec-
essary for the rational design of a rapid and generalizable structure-switching SELEX 
method.  
 Bowser and coworkers have demonstrated the power of CE as a selection plat-
form for traditional aptamers, obtaining high-affinity sequences in as little as one round 
of selection.20 Several groups have worked on advancing CE-SELEX methods, but these 
methods all hinge upon the target being large enough to cause a change in electropho-
retic mobility of the library upon binding. Unfortunately, small molecules are not of a suf-
ficient size to induce a considerable migration shift upon binding to the library. Therefore, 
the generation of small-molecule aptamers requires a CE method that must be designed 
to allow for a significant change in mobility regardless of target size. We envision that an 
approach that requires a displacement event to occur upon binding will effectively modu-
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late the mobility of bound and unbound library members and thus allow for the direct se-
lection of small-molecule structure-switching biosensors. 
As a proof of concept, our current work is focused on optimizing a novel CE 
structure-switching SELEX method for the aminoglycoside tobramycin. Tobramycin was 
chosen because, while it contains a high level of functionality, allowing for ease of selec-
tion, it is still small enough to result in little to no change in migration under normal CE-
SELEX conditions. To induce a migration shift, we have incorporated a structure switch-
ing element that is dependent upon tobramycin binding. This is accomplished through 
the use of a short capture strand with bulky drag tag that is complementary to a short 
docking region contained in the random library. Upon binding to tobramycin, the target-
bound library members that undergo a structural change that displaces them from the 
capture strand will be considerably smaller as a result of separation from the bulky drag 
tag. This results in a large change in the migration, allowing for efficient partitioning of 
bound and unbound library members. While use of streptavidin and PEG as drag tags 
failed to provide sufficient separation, preliminary work using latex microspheres has 
shown high levels of partitioning. In addition, the use of latex microspheres as the drag 
tag has resulted in lower background binding when compared to magnetic bead-based 
methods. We envision that this will provide a novel method to produce high affinity small-
molecule structure-switching biosensors.  
Our results provide insight into potential solutions to biosensor engineering, 
which is what we regard as currently the greatest limitation within the aptamer field. We 
anticipate that our extensive work into the direct selection of aptamer biosensors will 
help to drive an expansion of the known small-molecule aptamers that can function as 
displacement strand biosensors. Aptamer technology is at a crucial phase where new 
uses for aptamer biosensors are far outpacing the creation of new sensors for unique 
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targets. The integration of these new technologies therefore hinges upon the discovery 
of a robust, rapid, and generalizable method for selecting biosensors for new targets. 
Upon realization of a generalizable structure-switching SELEX method, the future 
direction of this research is expected to drive enzyme evolution through the use of ap-
tamer biosensors. We anticipate that our high-throughput enantioselective enzyme 
screening technique, described in Chapter 2, can be used to rapidly screen large en-
zyme libraries and determine the best mutant enzymes for nearly any reaction. This will 
greatly increase the speed of enantioselective enzyme evolution as well as the quality of 
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TABULAR  AND OMITTED DATA OF CHAPTER 2 
excitation/emission 
wavelength FAM FAM/HEX HEX 
490/520 nm 72589 75052 81 
524/572 nm 228 79944 88050 
Figure A1: Demonstrating orthogonality of FAM and HEX.  Table shows values for 
relative fluorescence intensity. 
Table A1: Tabular data for Figure 2.3 
aptamer:complementary 
strand ratio 1000 PM 100 PM 10 PM 1 PM 
1:3 15108 12750 12943 12773 
1:2.5 24884 17645 13813 12986 
1:2 42292 22919 16094 13748 
1:1.5 79129 42881 20352 15382 



















Table A2: % Displacement in calibration curve experiments Figure 2.7a.  Error 
represents the standard deviation of three independent trials. 







100 23.36 0.43 0.00 0.29 
99 22.83 0.46 0.15 0.27 
98 22.99 0.57 0.84 0.36 
97 23.02 0.59 0.95 0.44 
96 22.71 0.63 1.54 0.33 
95 22.60 0.66 1.99 0.25 
94 22.14 0.58 2.08 0.37 
93 22.22 0.75 2.36 0.33 
92 21.40 0.46 2.73 0.26 
91 21.67 0.48 3.06 0.34 
90 21.59 0.80 3.57 0.37 
80 20.96 0.89 6.22 0.19 
70 19.01 0.58 8.30 0.17 
60 17.47 0.42 10.50 0.25 
50 16.27 0.46 12.07 0.15 
40 13.24 0.44 12.41 0.33 
30 10.12 0.30 14.13 0.27 
20 7.22 0.29 14.77 0.29 
10 4.16 0.40 16.30 0.44 
9 3.90 0.38 16.51 0.44 
8 4.32 0.42 16.60 0.62 
7 3.68 0.34 17.24 0.54 
6 2.87 0.40 16.78 0.79 
5 2.67 0.21 16.87 0.42 
4 2.47 0.40 16.68 0.30 
3 1.01 0.27 17.29 0.31 












     
 
Equations from non-linear fit analysis:  
D-DNA   %D = ହଶǤଶכ௫ସଵǤହା௫      R
2 = 0.9979 
L-DNA   %D = ଺଴Ǥ଻כ௫ଷଽǤ଴ା௫       R




Table A3. Comparison of actual vs measured % L-Tym Figure 2.7b.  Deviation is the 
difference between actual and measured and error is represents the standard deviation 




% L-Tym Error Deviation 
100 99.56 0.37 0.44 
99 98.81 0.67 0.19 
98 98.00 1.03 0.00 
97 97.86 0.62 0.86 
96 93.78 1.07 2.22 
95 93.95 0.81 1.05 
94 93.75 0.77 0.25 
93 92.09 0.59 0.91 
92 90.08 1.64 1.92 
91 91.05 0.54 0.05 
90 90.22 0.60 0.22 
80 80.22 0.65 0.22 
70 71.13 0.17 1.13 
60 57.30 0.67 2.70 
50 49.14 0.83 0.86 
40 41.05 0.55 1.05 
30 30.26 0.66 0.26 
20 20.04 1.07 0.04 
10 10.94 0.67 0.94 
9 9.32 0.64 0.32 
8 8.90 0.52 0.90 
7 6.88 0.55 0.12 
6 6.06 0.78 0.06 
5 5.66 0.44 0.66 
4 4.31 0.74 0.31 
3 2.60 1.18 0.40 
2 2.30 0.98 0.30 
1 0.62 0.47 0.38 



























2 -0.140 0 0 0 0 0 0 0 
4 -0.216 0.756 0.60 2.28 0 0.82 1.79 0.27 
6 -0.710 2.81 0 4.48 0 2.56 0.45 2.42 
8 -0.76 4.22 1.20 6.85 1.74 4.10 1.39 5.50 
10 -1.35 4.77 1.06 8.64 1.84 7.23 3.08 11.42 
20 -2.45 12.03 3.14 18.87 3.55 16.90 5.42 29.23 
30 -2.55 12.50 6.52 23.88 3.41 24.09 11.29 30.66 
40 -2.08 17.52 2.91 31.34 4.00 28.55 9.57 41.36 
50 0.847 27.34 4.80 31.03 4.46 33.16 9.28 53.14 
60 -1.25 29.35 5.73 39.64 5.13 42.05 11.03 63.80 
70 0.763 33.23 6.64 44.14 4.82 40.29 10.43 67.30 
80 0.755 38.33 6.41 52.93 7.43 47.94 13.13 67.08 
90 -1.85 35.56 6.23 48.76 8.40 48.38 12.79 68.02 
100 -1.64 42.83 8.64 50.46 9.80 54.55 14.98 68.17 
110 0.382 38.96 8.63 54.77 10.04 61.84 16.58 77.60 
120 0.717 40.40 7.80 59.24 10.24 57.31 16.86 74.38 
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SPECTRAL DATA OF CHAPTER 4
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